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CHAPTER 1: GENERAL INTRODUCTION 
Catharanthus roseus commonly called Madagascar periwinkle is a medicinal 
plant belonging to the family Apocynaceae (Gajalakshmi et al., 2013). Even though the 
plant is native to Madagascar; it also could be found in Malaysia and has been called as 
Kemunting Cina (Ayob & Simarani, 2016) where it is popularly employed in 
landscaping or gardening due to its colourful flowers. This ornamental plant is also 
reported to be used as anticancer (Balaabirami & Patharajan, 2012) since it could 
produce a lot of important compounds, especially Vinca alkaloids such as vinblastine 
and vincristine (Krishnan, 1995; Manganey et al., 1979). Besides, this plant produces 
vindoline and catharanthine, which are the major monomer alkaloids as well as a 
biosynthetic precursor for vinblastine and vincristine (Noble, 1990). 
In view of the importance of these alkaloids in the medical applications, several 
studies have been made to discover the potential source for these metabolites. The 
plant’s associated microorganisms are believed to be able to produce similar 
metabolites as their host plant. Associated microorganism could be as symbiosis 
endophytes, are microbes that refer to microorganisms that live inside the tissues of 
plants without causing any apparent harm or diseases to the host plant (Petrini, 1991; 
Strobel, 2002). In fact, they promote the host plant’s growth and the formation of 
secondary metabolites related to the plant defence (Petrini, 1991; Chandra et al., 2010). 
The microorganisms could produce valuable bioactive compounds with a varied 
application in both research and applied fields (Ravindra et al., 2014). Endophytes also 
recognized as rich sources of secondary metabolites of multifold importance (Tan & 
Zou, 2001) include enzymes and plant growth hormones (Carol, 1988). Some of these 
metabolites are bioactive compounds that demonstrated potent anticancer, antibacterial 
and antiarthritis activity. 
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Fungi are one of the endophytic microorganisms that could be found in a plant. 
By having a wide spectacular array of shapes, sizes and colours, this species diversity 
actually remains unexplored (Srinivasam & Muthumary, 2007). Endophytic fungi spend 
the whole part of their life cycle living symbiotically within the healthy tissues of the 
host plant (Tan & Zou, 2001; Ravindra et al., 2014). It also has been recognized  as one 
of the important and novel resources of natural bioactive products (Strobel et al., 2004) 
since most endophytes are capable of synthesizing bioactive compounds that may 
provide plants with a defence against pathogens (Guo et al., 2008). Some of these 
compounds have proven useful for discovering a novel drug (Yan et al., 2011). There 
are many reports that endophytic fungi isolated from a medicinal plant produce a new 
drug or compound that similar to the host plants. All these findings will help to fill the 
demands of the drugs. In fact, the manufacturing cost of the drugs from endophytic 
fungi is cheaper than the production of the plants since it takes a shorter period to 
produce it. 
Breast cancer is a first killer for women in the world followed by cervical and 
ovarian cancer. World Health Organization (W.H.O) has estimated that by the year 
2030, 12 million people will be diagnosed with the breast cancer. Unfortunately, some 
people refused to get a cancer treatment since they afraid that they could not afford to 
pay for the high cost. Due to very expensive vinblastine and vincristine used in 
chemotherapy process for certain types of cancer including breast cancer. Naturally, 
these alkaloids were produced  by the Catharanthus roseus. However, this plant takes 
about one year before it is ready to be harvested and lead the high cost of production. 
Balandrin and Klocke (1988) reported it needs 500 kg of Catharanthus roseus’s leaves 
to produce 1 g of purified vinblastine and vincristine that cost ranging from 1 mil USD 
to 3.5 mil USD/kg (Chandra, 2012). 
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In 1960, vinblastine was introduced to treat certain types of cancer, including 
breast cancer, testicular cancer and Hodgkin’s disease (Armstrong et al., 1964). While 
in 1963, vincristine was introduced through oxidization of vinblastine to treat leukaemia 
(Evans et al., 1963). Thus, the flower of this plant was chosen as a logo for the National 
Cancer Council Malaysia (MAKNA) as a symbol of giving a hope for cancer patients 
(Appendix A). 
Currently, there are only three reports on these alkaloids produced by the 
endophytic fungi which were Alternaria sp., Fusarium oxysporum and unidentified 
fungi from Catharanthus roseus (Guo et al., 1998; Zhang et al., 2000; Yang et al., 
2004). An alternative producer of these alkaloids in the short period is required where 
endophytic fungi could produce vinblastine and vincristine within a month. Thus, this 
research was carried out in order to find a new endophytic fungus that could be other 
source of anticancer compounds  from the host plant Catharanthus roseus. 
The objectives of the study are: 
1. To isolate and identify the endophytic fungi from Catharanthus roseus.
2. To determine the metabolites properties; antimicrobial and hydrolytic enzymes
produced by four identified strains of endophytic fungi. 
3. To study the phytochemical analysis and antioxidant properties of the
endophytic fungi isolated from Catharanthus roseus. 
4. To compare the effectiveness of anti-carcinogenic alkaloids; vinblastine and
vincristine produce by Catharanthus roseus and endophytic fungi on breast cell 
line cancer (MDA-DB 231) through MTT and apotopsis assays. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Medicinal plant  
Medicinal plants were used in many regions, especially in traditional Chinese 
and Indian medicine for years ago. It is still being used till now for many treatments all 
over the world. However, researchers always try to find an alternative source that can 
replace plants since it will become good practices and environmentally-friendly. Song et 
al. (2005) stated that medicinal plant provides a special environment for endophytes  
and there are a lot of endophytic fungi with novel bioactive natural products that can be 
obtained from the medicinal plant (Gomes et al., 2007). Thus, it is known as a good 
storage for endophytic fungi (Krishnamuthy et al., 2008) which is becoming an 
important source of various secondary metabolites and bioactive compounds valuable 
for the pharmaceutical industries (Khan et al., 2010). 
Agarwood (Aquilaria sinensis) is a fragrant wood that has been used in a 
traditional Chinese medicine and fragrance additive for over 2000 years (He et al., 
2005). It was followed by a few reports on this medicinal plant that has a significant 
activity of anti-cancer (Gunasekera et al., 1981), antidepressant activities (Okugawa et 
al., 1996), anti-flammatory activities (Zhou et al., 2008), antimicrobial and antitumor 
(Cui et al., 2011). All these activities (antimicrobial, anticancer and antimalarial) also 
found  in endophytic fungi from 81 types of Thailand  medicinal plants (Wiyakrutta et 
al., 2004). 
2.1.1 Catharanthus roseus  
Catharanthus roseus (L) G. Don is a herbaceous subshrub also known as Vinca 
rosea (Akhtar et al., 2007) from a family Apocynaceae and native to Madagascar. 
According to Nayak and Percira (2006), this plant is native to the Caribbean Basin and 
has historically been used to treat a wide assortment of disease. However, it is grown 
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commercially in certain regions, especially Australia, Africa, India and southern Europe 
for its medicinal uses (Kumar et al., 2013).  
C. roseus is observed as a rich source of pharmaceutically important terpenoid 
indole alkaloids (TIA) where it produced about 130 TIA (Wang et al., 2011) and more 
than 200 important compounds (Krishnan, 1995). Catharanthine and vindoline are 
major monomer alkaloids and biosynthetic precursors to the dimeric alkaloids; 
vinblastine and vincristine (Figure 2.1). These two well-known anticancer drugs used in 
the treatment of acute leukaemia, Hodgkin’s disease (Noble, 1990) and extensively used 
in modern medicine as potential anticancer compounds (Krishnan, 1995; Jaleel et al., 
2008) as an anticancer chemotherapeutic (Pasquier & Kavallaris, 2008). 
 
 
Figure 2.1: The chemical structures of main Vinca alkaloids vinblastine, vincristine and 
their monomeric precursors; vindoline, catharanthine from C. roseus (Mu et al., 2012). 
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Other alkaloids produced by this plant and commercially been used in the 
pharmaceutical industry are ajmalicine and serpentine which are known as hypertension 
and anxiety drugs respectively (Hedhili et al., 2007) (Figure 2.2). The difference 
between these alkaloids and main alkaloids (vindoline, catharanthine, vinblastine and 
vincristine) is the source of plant materials. It can be extracted from the roots of 
Catharanthus roseus, instead of leaves part (Iwase et al., 2005). 
 
Figure 2.2: The chemical structures of ajmalicine and its oxidized form, serpentine 
from C. roseus (Hirata et al., 1987). 
 
Even though there are more than 2000 TIA synthesized by different families of 
plant species  (Gerasimenko et al., 2002; Barleben et al., 2007; Guirimand et al., 2010), 
there are no other plant species that can synthesize vinblastine and vincristine since they 
need a monomer  alkaloids as a biosynthetic precursor to the dimeric alkaloids (Van der 
Hajden et al., 2004) and lead the price of these alkaloids become expensive.  
2.2 Endophytes  
Endophyte is defined as an organism that colonized intra and intercellular 
internal plant tissues (Fouda et al., 2015). It refers to microorganisms; fungi, yeast and 
bacteria. They reside or invade the tissues of living plants without causing any disease 
or injury to them (Chandra et al., 2010), and have proven to be rich sources of bioactive 
natural products (Li et al., 2006; Tan & Zou, 2001). It is because they develop a special 
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mechanism to be inherent in the host plant by penetrating tissues and forms a close 
association. Kogel et al. (2006) reported this mutualism interaction between endophytes 
and host plants may result in fitness benefits for both partners. The endophytes may 
provide protection and survival conditions to their host plant by producing a plethora of 
substances which, once isolated and characterized, may also have potential for use in 
industry, agriculture, and medicine (Strobel & Daisy, 2003). Chandra (2012) also found 
out that the metabolic interactions between endophytes and its host plant may favour the 
synthesis of some similar secondary metabolites such as enzyme and antimicrobial 
properties. 
Hence, the study of endophytes including their distributions, biodiversity, 
biochemical characteristics, secondary metabolites, agents of biological control and 
other useful characteristics would be found by further exploration of endophytes 
(Selvanathan et al., 2011) since it is relatively unstudied and potential sources of novel 
natural products for exploitation in medicine, agriculture and industry (Strobel & Daisy, 
2003). According to Guo et al. (2008) and Yan et al. (2011), most endophytes are 
capable of synthesizing bioactive compounds that might be used as a defence against 
pathogens and some of the compounds have been proven useful for novel drug 
discovery. 
In fact, endophytes are likely to be a rich and reliable source of genetic diversity 
and biological novelty (Bacon & White, 2000) and previous research has proven that 
novel endophytic microbes usually produce novel natural products (Strobel, 2002).  It 
happened when endophytes are able to develop special metabolites to penetrate inside 
the host tissue, residing in mutualistic association and later their biotransformation 
abilities open a new platform for the synthesis of novel secondary metabolites 
(Chandra, 2012). They produce metabolites to compete with the epiphytes and also with 
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the plant pathogens toward maintaining the critical balance between fungal virulence 
and plant defence (Chandra, 2012). 
2.3 Endophytic fungi 
Plant endophytic fungi are defined as the fungi which spend the whole or part of 
their life cycle by colonizing inter and/or intracellularly inside the healthy tissues of the 
host plants and causing no apparent harm to the host (Zhang et al., 2006). There are 
approximately 30,0000 known plant species may host at least one endophytic fungi 
(Strobel & Daisy, 2003). 
According to Dreyfuss and Chapela (1994), there are two basic groups of 
endophytic fungi; i) Generalist, which is found in high abundance among different plant 
species. ii) Singleton which is found in low abundance and in specific host plants. This 
relationship may have begun from the time that higher plants first appeared hundreds of 
millions of years ago where an evidence of plant-associated fungi has been discovered 
in fossilized tissues of stems and leaves (Taylor et al., 1999) where it has been reported 
to be associated with plants for over 400 million years (Krings et al., 2007). It has 
estimated that there are about 1.3 million species of endophytic fungi all over the world 
(Dreyfuss & Chapela, 1994). However, it is estimated that there are over 1 million of 
them are wasting in nature (Petrini, 1991). 
Therefore, a lot of research has been done on endophytic fungi in order to keep 
it useful to human life and nature. Until now, plant endophytic fungi have been 
recognized as important and novel resources of natural bioactive products with a 
potential application in agriculture, medicine and food industry (Strobel et al., 2004; 
Gunatilaka, 2006; Verma et al., 2009) and a rich source of novel organic compounds 
with interesting biological activities and a high level of biodiversity (Giridharan et al., 
2012). In fact, due to the chemical constituents of medicinal plants were complex, more 
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and more endophytic fungi with novel metabolites of pharmaceutical importance were 
isolated from medicinal plants and a series of new and useful compounds were obtained 
(Huang et al., 2007; Guo et al., 2008; Kusari et al., 2009). They also play important 
physiological (Malinowski et al., 2004) and ecological (Malinowski & Belesky, 2006) 
roles in plant symbiosis, which protect their hosts from infectious agents and stressful 
environment by secreting bioactive secondary metabolites (Sun et al., 2014) and a 
number of bioactive constituents for helping the host plants to resist external biotic and 
abiotic stresses. On the other hand, the host plants can supply plenteous nutrient and 
easeful habitation for the survival of endophytic fungi (Rodriguez et al., 2009; Silvia et 
al., 2007).  
Thus, there is no doubt that exploring a variety of new natural products from 
endophytic fungi of medicinal plants have become a hot spot of new drug research (Cui 
et al., 2011). Stierle et al. (1993) has become the founder that discovered first bioactive 
compounds paclitaxel (Taxol) from the endophytic fungi Taxomyces andreanae in 
1993. Since some endophytic fungi have developed the ability to produce the same or 
similar bioactive substances as they originated from their host plants (Zhang et al., 
2006), it leads the researchers become more interested studying endophytic fungi as a 
potential producer of a novel and biologically active compounds with antimicrobial, 
insecticidal, cytotoxic and anticancer activities (Table 2.1). These bioactive compounds 
could be classified as terpenoids, alkaloids, steroids, phenols, Quinones, lignans, and 
lactones (Zhang et al., 2006; Xu et al., 2008). However, sometimes endophytic fungi 
can be passive residents or act as an assemblage of latent pathogens in their host 
(Ganley et al., 2004). 
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Table 2.1: Bioactive compounds produced by endophytic fungi isolated from medicinal 
plants. 
 
Host plants Endophytic fungi Bioactive compounds References 
Taxus  
brevifolia 
 
Taxomyces  
andreanae 
Taxol Stierle et al., 
1993 
Taxus  
wallichiana 
 
Pestalotiopsis 
microspora 
Paclitaxol Strobel et al., 
1996 
Torreya 
 taxifolia 
 
Pestalotiopsis 
microspora 
Torreyanic acid Lee et al., 
1996 
Taxus  
brevifolia 
 
Taxomyces  
andreanae 
Paclitaxol Strobel, 2002 
Artemisia  
annua 
 
Colletotrichum 
gloeosporioides  
Artimisinin 
(antimalarial) 
Wang et al., 
2002 
Justicia   
gendarussa 
 Colletotrichum 
gloeosporioides  
Taxol Gangadevi & 
Muthumary, 
2008 
Nothapodytes  
nimmoniana 
 
Neurospora  
 crassa 
Camptotechin Kusari et al., 
2009 
Tamarindus   
indica 
 
Fusarium   
solani 
Taxol Merlin et al., 
2012 
Eugenia  
 jambolana 
 
Cephalotheca 
faveolata 
Sclerotiorin Giridharan et 
al., 2012 
Phyllanthus  
 amarus 
Trichothecium  
sp. 
Trichothecinol-A Tawaare et al., 
2014 
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Chandra et al. (2010) reported that endophytic fungi also promote the growth of 
the host plants and the formation of secondary metabolites related to plant defence. As a 
significant of these long-term associations, some of these endophytic fungi may have 
developed genetic systems that allow the exchange of information between themselves 
and the higher plants. The exchange would allow the endophytic fungi to be more 
efficiently coping with the environmental conditions and perhaps increase compatibility 
with the host plants (Petrini et al., 1992; Strobel & Daisy, 2003). 
2.3.1 Metabolites from endophytic fungi 
Plants have been used in the traditional medicine of many cultures for years and 
has been extensively documented (Kapoor, 1990) and it has been estimated about 
25,000 species of plants in the world and probably 10 % of them have been tested for 
some type of biological activities (Verpoorte et al., 1997). However, researchers always 
try to find alternative resources of bioactive compounds that have a potential to be used 
in various industries especially in the pharmaceutical industry. Furthermore, by 
discovering of endophytes as untapped resource of bioactive natural products, it means 
that all the damage for which plants were earlier being exploited can be synthesized 
from endophytic fungi associated with the plants, consequently reducing the 
requirement of any other part of the plant and sparing them from extinction in most 
places as well as the drugs could be available at low costs (Huang et al., 2007; Kusari et 
al., 2009). It's supported by Buss and Hayes (2000) where they reported the Mayans 
already used fungi were grown on roasted green corn to treat intestinal ailments nearly 
3000 years ago. 
As known, plants and endophytic fungi produce some similar metabolites 
through mutualism motion (Preeti et al., 2009). Baker et al. (2000) reported that natural 
products are naturally derived metabolites by-products from organisms, plants or 
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animals. It's supported by Tan and Zou (2001) where they are found to be a rich source 
of functional metabolites and fungi have been known to be a major source of active 
compounds used in medicine (Wiyakrutta et al., 2004). Hence, they represent a 
relatively unexplored ecological source, and their secondary metabolites are particularly 
active because of their interactions with their hosts (Krohn et al., 2007; Kharwar et al., 
2011). 
According to Chandra (2012), endophytes synthesis metabolites to compete with 
epiphytes with pathogens to colonize the host and also to regulate host metabolism in 
balanced association by possessing exoenzymes necessary to colonize their host and 
grow well in the Apo plastic washing fluid of the host. Once the roots are colonized, the 
association with the host becomes mutualistic. These allow growth of the host and stock 
the endophytes with enough nourishment to extensively colonize the host’s roots 
(Chandra, 2012). On the other hand, endophytes can produce bioactive metabolites to 
enhance the growth and competitiveness of the host besides to protect it from 
herbivores and plant pathogen (Guo et al., 2008; Yan et al., 2011).  
First secondary metabolite discovered by the researcher is Taxol produced by 
endophytic fungus Taxomyces andreanae which was isolated from Taxus brevifolia 
(Stierle et al., 1993) known as the pacific yew tree (George et al., 1994). This multi-
million drug is proved as an important antimitotic agent who is active against lung 
cancer, ovarian cancer, breast cancer, head-neck cancer and advanced forms of Kaposi’s 
sarcoma (Merlin et al., 2012) by inhibiting cell proliferation through binding to the β-
subunit of the tubulin heterodimers and promoting its polymerization (Kovacs et al., 
2007). 
This finding also proves endophytic fungi that experience a long-term 
coexistence in direct contact with the host have exchanged genetic material to share the 
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bioactive compound with their host (Wang & Dai, 2011; Nadeem et al., 2012). 
Traditionally, this bioactive compound is produced by a yew tree, but it required 10,000 
kg of the bark of this plant to obtain 1 kg of Taxol which is equivalent to 3,000 trees. In 
addition, each patient needs about 2 g of Taxol to complete course of treatment 
administered several times over many months (Dewick, 2009). Thus, this finding of 
secondary metabolites from endophytic fungi has given hope to the pharmaceutical 
industry. 
2.3.2 Antimicrobial 
Antimicrobial agents are undeniable as one of the most important therapeutic 
discovery of the 20th century. However, Peterson and Dalhoff (2004) have found that 
by way of the ‘antibiotic era’ which is barely five decades old, mankind is now faced 
with the global problem of emerging resistance in virtually all pathogens. It's supported 
by Eloff (2000) where his surveys have revealed that almost no group of antibiotics has 
been introduced in which resistance had not been observed based on the report by 
Murray and Lopez (1997). In their report, out of the 39.5 million of death in the 
developing world, 9.2 million were estimated to have been caused by infectious and 
parasitic diseases, and that 98 % of death in children in developing countries resulted 
mostly from infectious diseases. 
Thus, there is a need to search for new antimicrobial agents because infections 
disease is still a global problem due to the development and spread of drug-resistant 
pathogens (Read et al., 2011). Antibiotics are defined as low molecular weight organic, 
natural products made by microorganisms (Demain, 1981). The antibiotic resistance of 
bacterial pathogens has become a serious health concern and encourages the search for 
novel and efficient antimicrobial metabolites (Liang et al., 2012). Therefore, nowadays, 
an exploitation of novel classes of antimicrobial metabolites is increasingly noticeable 
14 
 
by investigating the diversity, ecological role, secondary metabolites and bioactivity of 
the endophytic fungi isolated from various medicinal plants (Vaz et al., 2009). 
Endophytes are a common source of the antibiotics where the natural products or 
bioactive compounds from these microbes have been observed to inhibit or kill a wide 
variety of harmful disease – causing agents, but not limited to phytopathogens as well 
as bacterial, fungi, virus and protozoa that affect humans and animals (Strobel & Daisy, 
2003). Thus, it has been the tremendous increase in concern in screening endophytes for 
their antimicrobial activities (Liang et al., 2012). Furthermore, antimicrobial 
metabolites produced by the fermentation of endophytic fungi have many advantages, 
including sustainable use, no destruction of resources, easy large-scale industrial 
production and quality control (Liang et al., 2012). 
2.3.3 Enzyme  
Endophytic fungi yield several metabolites including enzymes with a potential 
to hydrolyse several plant-derived macromolecules (Zaferanloo et al., 2013). Enzymes 
are biocatalysts protein in nature which catalyse the biochemical reaction taking place 
in the living cell without any overall change (Jain &  Jain, 2006) where they are 
obtained from plants, animals and microorganisms (Boboye & Ajay, 2011). Bacteria 
and fungi are mostly used organism for enzyme production (Maheswari & Sherley, 
2012) where it involved in the metabolism of carbohydrate including the trehalose 
metabolism in microbes either in association with another organism such as plants or 
when they are unaccompanied (Boboye, 2004). Plus, enzymes produced by 
microorganisms are so great coupled with their fast growth rates and the ease of enzyme 
recovery (Boboye & Ajay, 2011). 
According to Ajayi and Boboye (2012), microbes have some advance over 
plants and animals as sources of enzymes, especially endophytic fungi which have the 
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ability to produce abundant extracellular enzyme such as pectins, cellulase, lipase, 
amylase, laccase and protease (Sunitha et al., 2013). These fungal enzymes play the key 
role in the biodiversity and hydrolysis against pathogenic infection and to obtain their 
nutritional need from the host plants (Sunitha et al., 2013). However, Valipour et al.  
(2014)  reported that enzyme production by bacteria is greater since the growth rate of 
bacteria is usually higher than fungi.  
Different fungal strains produce a diverse enzyme with natural properties suited 
to the environmental conditions in which they must act (Webster & Weber, 2007). It is 
hypothesized that their metabolic compatibility has been strongly influenced by natural 
selection, such as it thrives in a competitive environment (Glover, 1995). Thus, by 
screening fungal resource for novel metabolites of enzymes and their application, it 
becomes major goals of current research to accomplish environmentally friendly 
technological development. (Poosarla et al., 2012).  However, bioactive product 
discovery are depending on the knowledge of habitats when fungi are abundant and the 
strength of culture collection (Hyde, 2001) as reported earlier by Biabani et al. (1998) 
that fungi have proven themselves invaluable sources of natural products for agriculture 
as well as biomedical development for over a half century. 
2.3.3.1 Cellulase 
Cellulase is a group of hydrolytic (Bhavsar & Bhalerao, 2012) and synergistic 
enzyme that is used to break up the cellulose into glucose or other oligosaccharide 
compounds (Chellapandi & Jani, 2008) (Figure 2.3). This enzyme is capable of 
degrading lignocellulose materials and has a wide range of applications (Bhavsar & 
Bhalerao, 2012). According to Enari (1983), cellulose the most abundant renewable 
material in the world and is an important raw material in sugars, biofuels and other 
industries. Thus, there is a considerable economic interest to develop processes for the 
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effective treatment and utilization of cellulosic waste as an inexpensive carbon source. 
Therefore, cellulase provides a key opportunity for exploring the tremendous benefits of 
biomass utilization (Lynd et al., 2002). 
Valipour et al. (2014) reported, it is estimated that approximately 20 % of a 
billion USD of the world’s sale of industrial enzyme consist of cellulase, hemicellulase 
and pectinase where these enzymes are used in textile, food (Balnave & Graham, 1995), 
brewery and wine as well as in pulp and paper industries (Sadler, 1993). The most 
endophytic fungi used as a cellulase producing fungi are Aspergillus, Rhizopus and 
Trichoderma sp. (Saito et al., 2003). Generally, the cellulase system in fungi is 
considered to comprise three hydrolytic enzymes i) endo-(1,4) -D-glucanase 
(endoglucanase, endocellulase, CMCase) which clears linkage at random commonly in 
the amorphous parts of cellulose. ii) exo – (1,4)- D-glucanase (cellobiohydrolase, 
exocellulase, microcrystalline cellulase) which release cellobiose from non-reducing or 
reducing and generally from the crystalline parts of cellulose. iii) Glucosidase 
(cellobiose) which relates glucose from cellobiose and short chain cello 
oligosaccharides (Bhat & Bhat, 1997) (Figure 2.4). 
 
Figure 2.3: The reaction of cellulase enzyme (Held, 2012). 
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Figure 2.4: The cellulase system in fungi which is divided into three groups 
(www.emeraldbiology.com). 
 
 
 
2.3.3.2 Amylase  
Amylase is universal enzyme being widespread in animals, fungi, plants, 
unicellular eukaryotes and prokaryotes, which is the most important enzymes used in 
biotechnology (Burhan et al., 2003). It is estimated that approximately 30 % of world 
enzymes production are amylase (Sivaramakrishnan et al., 2006) and followed by report 
from Maheswari and Sherley (2012) that this enzyme leading the world’s market with a 
65 % of enzymes production due to the high demand in various sectors such as food, 
pharmaceutical, textiles and detergents (Zaferanloo et al., 2013). However, this enzyme 
is widely used in the industry for starch hydrolysis (Maheswari & Sherley, 2012) 
(Figure 2.5). 
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Figure 2.5: The structure of starch polysaccharide and its digestion of glucose by using 
an amylase enzyme (Held, 2012). 
 
According to Maheswari and Sherley (2012) on their report, this enzyme is used 
commercially for the production of sugar syrups which is hydrolyzed from the starch 
which consists of glucose, maltose and higher oligosaccharide. Besides, it also catalyses 
the endo-cleavage of the α-1,4 glycoside linkages and release of short oligosaccharide 
with a  limitation of dextrin where the most important amylase for industrial and 
biotechnology applications are glucoamylases and α-amylases (Sivaramakrishnan et al., 
2006) (Figure 2.6). In order to meet the demands of this enzyme, low cost medium is 
required for the production of amylase. 
Therefore, this demand has driven the exploitation of endophytes as enzyme 
sources for promising industrial applications in agriculture, medicine and food industry 
(Laird et al., 2006). Plant endophytic fungi spend the whole or part of their lifecycle 
colonizing the inside of healthy tissues of the host plants either inter/ and or intracellular 
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(Zhao et al., 2010) where fungal sources of amylase are mostly terrestrial isolating such 
as Aspergillus sp. (Zaferanloo et al., 2013). 
Figure 2.6: The structure of amylopectine with amylase action; a: α-amylase, b: 
amyloglucosidases, c: β-amylase and d: isoamylase and pullulanase (Miguel et al., 
2013). 
2.3.3.3 Protease 
Protease constitutes one of the most significant groups of industrial enzyme that 
are now used in a widespread range of industrial enzymes such as detergent, food, 
pharmaceutical, leather and silk industries (Adinarayana et al., 2003) due to the its 
physiological functions ranging from generalized protein digestion to the more specific 
regulated processes (Mussarat et al., 2000). This enzyme hydrolyzes peptide bonds of 
proteins and breaks them down into polypeptides or free amino acids (Figure 2.7). Thus, 
it differs in its substrate specificity, catalytic mechanism and active site (Sumantha et 
al., 2006).  However, bacterial protease is the most substantial compared with plant, 
animal and fungal protease since they possess almost all characteristics desired for their 
biotechnological application (Rao et al., 1998). 
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Figure 2.7: The basic chemical structure of a protein’s amino acid, which are connected 
by a peptide bond and the presences of protease to cut the proteins into two fragments 
(Donohue and Osna, 2004). 
 
2.3.4 Antioxidant 
Antioxidant is defined as a compound that can delay, inhibit or prevent the 
antioxidant of oxidisable materials through scavenging free radicals and diminishing 
oxidative stress (Dai & Mumper, 2010). This is supported by Halliwell et al. (1995) 
from their report that antioxidant is any substances that present anti-tumour at low 
concentration compared to those of an oxidizable substrate significantly delays or 
prevents oxidation of that substrate. The mechanism of this antioxidant compound is by 
associating with decreased DNA damage; diminished lipid peroxidation maintained 
immune functions and inhibited malignant transformation of cells (Gropper et al., 
2009). Antioxidant properties can be determined using few methods such as DPPH 
scavenging activities, ferric reducing antioxidant power and ferrous chelating activities. 
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However, DPPH scavenging activity is the most popular method to determine the 
antioxidant properties since it is a simple method (Huang et al., 2005). 
DPPH is stable and nitrogen – centred free radical which produces violet colour 
in ethanol solution (Pushpalatha et al., 2011) with a chemical compound of C18 H12 N5 
O6. According to Huang et al. (2005), by being a stable free radical, the DPPH assay is 
used to evaluate the ability of antioxidant to scavenge free radicals. It gives reliable 
evidence concerning the antioxidant ability of the tested compounds to act as free 
radical scavengers or hydrogen donors. It is supported by Yamagushi et al. (1998) when 
DPPH free radicals become paired with hydrogen from a free radical scavenging 
antioxidant, its purple colour fades rapidly to yellow to form reduced DPPH-H (Figure 
2.8). Hence, it was reduced to a yellow coloured produced with the addition of the 
fractions in a concentration (Pushpalatha et al., 2011). 
Figure 2.8: The mechanism of DPPH reaction on radical scavenging activity where the 
DPPH compound in purple colour changed into yellow colour as a reaction receiving      
the hydrogen from the other compound (Perez and Aguilar, 2013). 
Therefore, the studies on antioxidant activities are important for pharmaceutical 
industries. Part of that, the major groups of phytochemicals that have been suggested as 
a natural source of antioxidant may contribute to the total antioxidant activity of plant 
material, including polyphenols, carotenoid and traditional antioxidant vitamins such as 
vitamin C and E (Maisarah et al., 2013). Phenolic is a compound possessing one or 
more aromatic rings with one or more hydroxyl groups (Dai & Mumper, 2010) and has 
DPPH DPPH-H 
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been considered as a powerful antioxidant in vitro and proved to be more potent 
antioxidant than vitamin C, vitamin E and carotenoids (Rice-Evans et al., 1996) where 
natural phenolic can affect basic cell functions that related cancer development by many 
different mechanisms. Generally, the mechanisms of phenolic compounds for 
antioxidant activities are neutralizing lipid free radicals and preventing decompositions 
of hydro peroxides into free radicals (Li et al., 2006) due to the presence of hydroxyl 
groups (Pushpalatha et al., 2011). 
According to Hodek et al. (2002), first of all in the initiation stage, phenolic may 
inhibit the activation of pro-carcinogen by inhibiting phase 1 metabolizing enzyme such 
as cytochrome. Then, it may inhibit the formation and growth of tumours by induction 
of cell cycle arrest and apoptosis. Malignant cells are characterized by excessive 
proliferation, inability to terminally differentiate or perform apoptosis under normal 
conditions and an extended or immortalized life span. The regulation of cell cycle is 
altered in these cells. Consequently, any perturbation of cell cycle specific proteins by 
phenolic can potentially affect and / or block the continuous proliferation of these 
tumorgenic cells (Dai & Mumper, 2010). 
2.3.5 Anticancer  
Cancer is a main killer disease for all women over the world and more than six 
million new cases reported every year (Chandra, 2012) (Figure 2.9) where it is a multi-
step disease, incorporating environmental, chemical, physical, metabolic and genetic 
factors which play a direct and/ or indirect role in the induction and deterioration of 
cancers (Lv et al., 2010). It occurs when cells become abnormal and keep dividing and 
forming new cells without any control (Chandra, 2012) (Figure 2.10). Nowadays, breast 
cancer becomes serious threat to women’s health in the world (Zhang et al., 2013) 
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where almost 30 % of early stage breast cancer patients eventually develop recurrence 
and metaphases (Lv et al., 2010). 
 
Figure 2.9: The estimated new cases and deaths in America (American Cancer Society-
www.m.cancer.org, 2016). 
 
 
Figure 2.10: The development of cancer cells (Cancer Research UK, 2016). 
 
 
Thus, the chemotherapeutic drugs are used as a treatment for cancer, which is 
usually DNA damaging agents and these drugs invariably result in the DNA strand 
breakage, chromosome breaks and / or gain chromosomes. These DNA damaging 
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agents has been reported to cause phenotypic abnormalities like spontaneous abortion, 
congenital malformations and malignant transformations (Sandberg, 1980).  
Reasearch showed that the use of these regimens has resulted in the increased 
survival of patients receiving the treatments. However, chemotherapeutic agents and 
radiation cause DNA harm not only to the malignant cells but the normal cells also 
suffer damage to their genome. This damage could be boosted when both cytotoxic 
drugs and radiation are combined for therapeutic purposes. This may result in the 
reduction of the latency period of neoplastic transformation and the assessment of 
chromosomal damage helps to predict the mutagenicity and carcinogenicity of these 
agents (Devi et al., 2012). 
2.3.5.1 Anti-carcinogenic vinblastine and vincristine  
According to Tikhomiroff and Jolicoeur (2002), the production of secondary 
metabolites by plant cells and tissues has become and active field of study because of its 
potential as a source of valuable pharmaceutical compounds. C. roseus (Apocynacea) is 
found to contain alkaloids about 100 which have been isolated so far (Hughes & 
Shanks, 2002). C. roseus has historically been used to treat a wide assortment of disease 
since it contains over 130 compounds and many of which have cytotoxicity (Noble, 
1990; Zu et al., 2006). Sertel et al. (2011) reported that the attention in this species 
arises from its therapeutic role as the source of the anticancer alkaloids; vinblastine and 
vincristine. These Vinca alkaloids are prescribed for a wide variety of cancers including 
non-small cell lung cancer, breast cancer, bladder cancer, lymphomas and leukaemia 
(Damen et al., 2010).  Barnett et al. (1978) also reported earlier that vinblastine and 
vincristine are used as major drugs in the treatment of lymphoma and leukaemia since 
they are potent mitotic inhibitors that have been used clinically in the treatment of a 
variety of neoplasms (Fergus en et al., 1984) due to the their ability to lower the number 
of white blood cells (Chandra, 2012).   
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Thus, the secondary metabolite pathways of these Vinca alkaloids have already 
been documented (Morgan & Shanks, 1999; De Luca & Laflamme, 2001) and are quite 
complex (Tikhomiroff & Jolicoeur, 2002). Figure 2.11 showed the pathway of these 
alkaloids where it starts with a tryptophan and converted to tryptamine. Tryptamine is 
considered with secologanine to produce strictocidine, the common precursor of all 
indole alkaloids and divided into three branches (Tikhomiroff & Jolicoeur, 2002). 
Figure 2.11: The pathway of Vinca alkaloids produced by C. roseus plant 
(Tikhomiroff & Jolicoeur, 2002). 
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Vinblastine and vincristine are bisindole antitumour alkaloids which are 
synthesized from the leaves and flowers of this plant and accumulate in very low 
concentration (Singh et al., 2008). Both of these terpenoid indole alkaloids are two well-
known anticancer agents which are derived from the coupling of vindoline and 
catharanthine monomers (Perez et al., 2002). Report from Potier (1980) and Tam et al. 
(2010) showed that these alkaloids are commercially produced semi-synthetically by 
dimerization of their natural precursor’s vindoline and catharanthine.  
 
Figure 2.12: The chemical structures of vinblastine and vincristine 
(www.chm.bris.ac.uk). 
Vinblastine has introduced in 1960 and used to treat specific types of cancer, 
including Hodgkin’s disease, breast cancer, testicular cancer and non- small cell living 
cancer while vincristine is an oxide form of vinblastine and was introduced in 1963 
used in the treatment of acute lymphoblastic leukaemia (Armstrong, 1964). Even 
though both of these alkaloids differ in their molecular structure by only one carbonyl 
group (Figure 2.12), vinblastine and vincristine exhibit quite different spectra of activity 
in both their targets of antitumor activity and their site of dose limiting toxicity 
(Fergusen et al., 1984; Mu et al., 2012). 
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The anticancer activity of these alkaloids has prevented mitosis in metaphase 
and they bind to tubulin thus prevent the cell from making the spindles it needs to 
divide. Their intracellular binding to tubulin with the subsequent dissolution of 
microtubules and arrest of cells in mitosis is considered necessary to mediate their 
cytotoxic action (Creasey, 1979). Hence, it is attributed to their ability to disrupt 
microtubules causing the dissolution of mitotic spindles and metaphase arrest in 
dividing cells (Jordan & Wilson, 2004; Zu et al., 2004) (Figure 2.13). 
Figure 2.13: The mechanism of destabilization of microtubules by Vinca alkaloids 
(Turin University-www.flipper.diff.org). 
Although these alkaloids have only minor structural differences and behave in 
the same way at the level of drug tubulin interaction (Himes et al., 1976; Owellen et al., 
1977) their toxicity and spectrum of clinical activity differ considerably (Chandra, 
2012). Other reports showed that the primary action mechanisms of vincristine are via 
interference with microtubule formation and mitotic spindle dynamics, disruption of 
intracellular transport and decreasing tumour blood flow with the latter probably as a 
consequence of anti- angiogenesis (Damen et al., 2010; Moore et al., 2009; Kavallaris et 
al., 2008 and  Perez et al., 2002) 
Even though vinblastine and vincristine have important pharmacological 
activities, both of them are synthetically challenging (Demain & Vaishnar, 2011) 
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because these alkaloids are species specific (Van der Hajden et al., 2004) which is only 
could be produced by C. roseus plant only. Thus, alternative sources of these alkaloids 
always being searched. Guo et al., (1998) first reported endophytic fungi Alternaria sp. 
isolated from the phloem of C. roseus that had the ability to produce vinblastine. Later, 
Zhang et al. (2000) discovered an endophytic fungi Fusarium oxysporum from the 
phloem of C. roseus that could produce vincristine and followed by reports from Yang 
et al. (2004) also found an unidentified vincristine producing fungi from the leaves of C. 
roseus. Plus, Joel and Bhimba (2012) discovered crude extracts of 84 endophytic fungi 
had anticancer activities against A375 (human malignant melanoma), SW620 (human 
colorectal adenocarcinoma) Kato III (human gastric carcinoma), HepG2 (human liver 
hepatoblastoma) and Jurkat (human acute T cell leukaemia). 
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CHAPTER 3: ISOLATION AND IDENTIFICATION OF 
ENDOPHYTIC FILAMENTOUS FUNGI                                                          
FROM Catharanthus roseus 
3.1 Introduction  
Catharanthus roseus commonly called Madagascar periwinkle is herbaceous 
sub - shrub of latex producing plants belonging to the family Apocynaceae 
(Gajalakshmi, 2013). This plant is a native to Madagascar but also found in Malaysia, 
where it is called Kemunting Cina and is popularly employed in landscaping or 
gardening due to its colourful flowers. This ornamental plant is also reported to be used 
as anticancer where it produced the alkaloids called vincristine and vinblastine 
(Balaabirami & Patharajan, 2012). The report on the medicinal efficacy of this plant 
incurs the current surge in its global market, thus the flower of this plant was chosen as 
a logo for the National Cancer Council Malaysia (MAKNA). However, this plant takes 
about one year to harvest and lead to the high cost of production. Alternative producer 
of these alkaloids in the short period is required.  
In view of the importance of these alkaloids in the medical applications, several 
studies have been made to discover the potential source for this metabolite. The plants 
associated microorganisms are believed to be able to produce similar metabolites as 
their host plant. Endophytes are microbes that colonize healthy tissues of the plant for at 
least part of their life cycle without causing any apparent disease symptoms in their host 
(Petrini, 1991). These endophytes are also recognized as rich sources of secondary 
metabolites of multifold importance (Tan & Zou, 2001) including enzymes and plant 
growth hormones (Carol, 1988). Some of these metabolites are bioactive compounds 
that demonstrated potent anticancer, antibacterial and antiarthritis activity.  
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Endophyte microorganisms that could be found in plants including fungi. By 
having a wide spectacular array of shapes, sizes and colours, this species diversity 
actually remains unexplored (Srinivasam & Muthumary, 2007). The capability of these 
fungi to grow and produce their metabolites within 2 - 4 weeks become more economic. 
Thus, the objective of this study is to identify fungi strains isolated from a medicinal 
plant, Catharanthus roseus through a molecular technique and observation of 
morphological characteristics.  
3.2 Materials and methods 
3.2.1 Plant sample collection, preparation and fungal isolation 
The root and leaves of two types of wild grown Catharanthus roseus (purple 
and white) were taken from a peat soil in Alor Setar, Kedah (6.1167 °N, 100.3667 °E) 
which is the northern part of Peninsular Malaysia. The fungi strains were isolated 
according to Robert and Terry (1978). The root samples were cleaned under running tap 
water to remove the soil particles. The cleaned samples of roots and leaves were cut into 
1 cm size and surface sterilized was done by immersion in 10 % (v/v) bleach for 15 
min. Then, it was rinsed using distilled water for 5 min and blotted dry with a sterile 
paper. The piece of samples was placed on Malt Extract Agar (MEA: OXOID). Plates 
were incubated at 25 °C and observed daily (Appendix B). The seven days old of fungal 
culture were cut into small plug of mycelium using sterile borer and transferred to a 
new plate of Malt Extract Agar (MEA). Sub culturing was repeated several times in 
order to get a pure culture. The pure culture was maintained on Potato Dextrose Agar 
(PDA) slant agar at 4 °C. 
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3.2.2 Identification of fungi 
3.2.2.1 Molecular identification 
a. DNA extraction and PCR amplification
Deoxyribonucleic Acid (DNA) was isolated from fresh mycelia taken from the 
surface plate of each endophytic fungus. The DNA was recovered from scrapped 
mycelia using i-Genomic BYF DNA Extraction Mini Kit (Intron Biotechnology, Inc.) 
according to manufacturer’s instructions. The quality of genomic DNA was evaluated 
using a Nanodrops spectrophotometer (Thermo Scientific) and followed by 1 % (v/v) 
agarose gel electrophoresis. 
The Polymerase Chain Reaction (PCR) amplification was conducted using 
universal primer Internal Transcribed Spacer Ribosomal DNA (ITS rDNA). ITS 1F 
(forward primer 5’ CTT GGT CAT TTA GAG GAA GTA A 3’) and ITS 4 (reverse 
primer 5’ TCC TCC GCT TAT TGA TAT GC 3’) (White et al., 1990). The 20 µL PCR 
reaction mixture contained 4 µL of buffer, 1.2 µL of MgCl2, 2 µL of dNTP, 0.6 µL of 
primer F, 0.6 µL of primer R, 10.4 µL of distilled water and 1 µL of DNA. The PCR 
was performed using 2720 PCR Thermo Cycler followed the standard procedure: initial 
denaturation at 94 °C for 1 min followed by 35 cycles for each denaturation (94 °C for 1 
min), annealing (51 °C for 1 min) and extension (72 °C for 1 min). The last stage was 
the final extension at 72 °C for 8 min and cooling to 10 °C. Then, these PCR products 
were analysed on electrophoresis using 1 % (v/v) agarose gel that was run at 100 v, 400 
mA for 30 min. The gel was stained with ethidium bromide and a band was 
photographed on a UV light transilluminator. 
The amplicons were cleaned after ascertaining their integrity before automated 
sequencing directions. The sequences were then aligned using the data from a GenBank 
at the NCBI (http://www.ncbi.nlm.nih.gov) and the most identical sequences of fungi 
were identified. 
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3.2.2.2 Morphological identification 
The isolated fungi were identified based on the morphology and cultural 
characteristics. It included the colours of spores and growth profiles of the colonies. 
Meanwhile, the microstructures of each fungus were observed under scanning electron 
microscope (SEM). 
a. Physical assessment 
A 1 cm diameter agar disk from the margin of seven days old growing colony of 
each isolate grown at 25 °C was used to centrally inoculate each replicate. The plates 
were incubated at the same condition above and the experiment consisted of three 
replicates (n=3). Assessment of growth was made daily during the seven days 
incubation period. For each colony, the mean radial mycelia growth was calculated by 
measuring two different colony radii on each of the three plates. The growth was 
corrected by subtracting the 1 cm diameter of the original plug of inoculum and plotted 
against time. 
b. Microstructure analysis 
The microstructures of spore and hyphae configuration of these fungi were 
investigated from seven days old fungal culture. The specimen was cut into a small size 
(3 mm) and soaked in 8 % (v/v) of Glutaraldehyde and Sorenson’s Phosphate Buffer 
(1:1) for 1 h. Then, the samples were washed using distilled water and Sorenson’s 
Phosphate Buffer (1:1). After that the samples were fixed into 4 % (v/v) of osmium and 
distilled water (1:3) for 14 h. Next, all the samples were dehydrated in an ascending 
series of ethanol from 10 % to 90 % (v/v) for 15 min each. Then the samples were 
soaked twice in 100 % (v/v) of ethanol (15 min each) before transferring into 
intermediate fluids of ethanol – acetone mixture with a ratio of 3:1, 1:1, and 1:3 for 20 
min each. Finally the samples were soaked into 100 % acetone four times (20 min each) 
before proceeding to a Critical Point Drying (CPD) phase. The samples were coated 
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with gold in an ion-coating and viewed under a Scanning Electron Microscope (JEOL 
JSM-6400) (Appendix C). 
3.3 Results and discussion 
3.3.1 Molecular identification 
A total of five strains of filamentous fungi were isolated from leaves and roots 
of both varieties of Catharanthus roseus. These endophytic fungi were identified by 
using molecular technique. The high quality DNA extracted from these fungi was used 
for PCR by using ITS1 and ITS4 as a primer and a marker (100 bp). The PCR 
amplification of ITS regions successfully amplified the genomic DNA of the fungi 
(Figure 3.1). These DNA nucleotide sequences have been identified and deposited in 
European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/) with the accession 
number (Table 3.1). The result showed four different species of fungi were successfully 
identified and was confirmed through neighbour-joining tree using Molecular 
Evolutionary Genetics Analysis (MEGA) (Figure 3.2). 
 
Figure 3.1: The amplification of DNA from pure culture of fungi isolated from C. 
roseus using the primer set ITS1/ITS4. 1 and 3: Colletotrichum gloeosporioides,  2: 
Macrophomina phaseolina, 4: Nigrospora sphaerica,   5: Fusarium solani and M: 100 
bp DNA marker. 
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Table 3.1 Fungal species isolated from different varieties and tissues of C. roseus and respective accession number of their ITS 
sequences. 
Strain Host Plant Tissues Species Molecular 
size (bp) 
Similarity 
(%) 
Accession No. 
GenBank 
Accession No. 
ENA 
1 & 3 C. roseus (purple & white) Leaf Colletotrichum 
gloeosporioides 
530 100 KT 968450.1 HG 938365 
2 C. roseus (purple) Root Macrophomina 
phaseolina 
521 100 KC 822431.1 HG 938366 
4 C. roseus (white) Leaf Nigrospora 
sphaerica 
240 99 KC 505176.1 HG 938367 
5 C. roseus (white) Root Fusarium solani 541 100 JQ 277276.1 HG 938368 
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 0003 13
 0008 16
 0005 13
 0009 17
01234
Figure 3.2: Neighbour-joining tree of all endophytic fungi isolated from C. roseus, 
which were produced in MEGA 5. Strain 1 and 3 were C. gloeosporioides, and 
strains 2, 4 and 5 were M. phaseolina, N. sphaerica and F. solani respectively. 
3.3.2 Morphological identification 
Morphological characteristics had been studied to confirm the identification of 
these endophytic fungi. Table 3.2 and Figure 3.3 showed the morphological 
appearances of these endophytic fungi. 
Table 3.2: The morphological appearance of endophytic fungi isolated from different 
tissues and colours of C. roseus after a week incubated on Malt Extract Agar (MEA) at 
25 °C. 
Endophytic 
Fungi 
Host 
Plant 
Tissue Morphological Appearance 
Colletotrichum  
gloeosporioides 
C. roseus 
(purple) 
Leaf White coloured 
Macrophomina 
phaseolina 
C. roseus 
(purple) 
Root Light black coloured 
Nigropsora 
sphaerica 
C. roseus 
(white) 
Leaf Red to green coloured     
(turn the media into red coloured) 
Fusarium 
solani 
C. roseus 
(white) 
Root White and yellowish coloured 
Strain 3 
Strain 1 
Strain 2 
Strain 4 
Strain 5 
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Figure 3.3: Morphological appearances of endophytic fungi isolated from C. roseus. 
CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica and FS: F. solani. 
A study on the fungal growth on the MEA plate showed the rapid growth after 3 
days of cultivation. The observation was made only for seven days since the mycelia of 
most strains was compact and covered the entire Petri dish within a week except 
Nigropsora sphaerica. The mycelia growth curves of all strains are shown in Figure 3.4. 
The microstructures of fungi were observed under scanning electron microscope (SEM) 
to get the real shape and size of spore and hyphae for each fungus for more 
identification. The round shape of spores was observed from endophytic fungi 
Colletotrichum gloeosporioides, Macrophomina phaseolina and Nigrospora sphaerica 
while the spores of strain 2 were alike a raspberry shape. Meanwhile, only Fusarium 
solani showed a new moon shape of the spore.  All the fungi had a septate hyphae range 
from 12 µm to 25.6 µm (Figure 3.5).  
CG MP 
FS NS 
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Figure 3.4: The growth profiles of fungi strain isolated from C. roseus. All endophytic 
fungi were incubated for seven days on MEA at 25 °C. Values presented are the means 
± SD, (n = 3).  
Colletotrichum gloeosporioides has been isolated from both host plant’s leaf. 
Previously, this whitey coloured fungus was found by Sharma et al. (2013) and Koelsch 
et al. (1995) but as a plant pathogen to Catharanthus roseus plant. This species was 
rarely been found  in Catharanthus roseus compared to its genus Colletotrichum. Xuan 
et al. (2012) had found Colletotrichum sp. in Cephalotaxus hainanensis; the Chinese 
medicinal plant. Both of C. roseus and C. hainanensis plants produced alkaloids that 
had been used for anticancer and this fungus is expected could generate constituents 
which are similar to the host plants (Stierle et al., 1993). Macrophomina phaseolina also 
known as a soilborne fungus (Endraki & Banihashemi, 2010; Arias et al., 2011) was 
isolated from the root of C. roseus (purple). Nigrospora sphaerica is the imperfect 
fungus that was found in C. roseus (white) leaf. It has a unique appearance by changing 
the colour from white to dark green.  It is also able to secrete the metabolites that 
change the plate culture medium from brownish to red colour. This fungus was reported 
earlier as an endophytic or pathogenic fungus (Zhang et al., 2009) and only a few 
literatures on this fungus. Meanwhile, Fusarium solani with a new moon shape of spore 
was isolated from a white Catharanthus roseus’ root.   
3
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Figure 3.5: The scanning electron micrographs of endophytic fungi (a) strain 1, (b) strain 2, (c) strain 3, (d) strain 4 and (e) strain 5 showed a 
various shapes of spores (arrow) and hyphae. The spores and hyphae were observed under 20,000 x and 2500 x . 
a b c d e 
e d c b a 
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M. phaseolina, N. sphaerica and F. solani were reported as pathogens of many 
agricultural crops and plants (Anandi et al., 2005; Siavosh & Seyed, 2012).  This M. 
phaseolina causes seedling blight, root rot, and charcoal rot of more than 500 crops and 
non-crop species. It has a very wide distribution covering most of the tropics and 
subtropics, where high temperatures and water stress occur during the growing season.  
Initial infections occur at seedling stage, but remain latent until the plant approaches 
maturity. Plants may wilt and die.  Even though a lot of research were reported on 
endophytic fungi from C. roseus plant, these three strains; C. gloeosporioides, M. 
phaseolina and N. sphaerica have become new findings for this host plant (Table 3.3). 
According to Dreyfuss and Chapela (1994), there are two basic groups of 
endophytic fungi; i) Generalist, which is found in high abundance among different plant 
species. ii) Singleton which is found in low abundance and in a specific host plant. 
Endophytic fungi often are symptoms symbionts living within the above ground tissues 
of their angiosperm hosts and are not affected by surface sterilization techniques 
(Selvanathan et al., 2011). However, in this study, these three fungi may play an 
important role as endophytes. It is probably due to the flexibility of C. roseus in 
producing antimicrobial activity. Balaabirami and Patharajan (2012) reported that the 
leaf extract of C. roseus gave a positive result for antimicrobial test against Asperigillus 
niger. It was indicated that these fungi helped to synthesize bioactive agent that could 
be used by plants for defence against other pathogens (Selim et al., 2012). 
Thus, when these fungi became endophytes, it is believed to carry out a 
resistance mechanism in order to overcome a pathogenic invasion by producing 
secondary metabolites bearing antimicrobial activity (Selim et al., 2012). 
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Table 3.3: The endophytic fungi isolated from a C. roseus plant 
Endophytic fungi References 
Fusarium oxysporum Kumar & Ahmad, 2013 
Alternia sp. Sreekanth et al., 2017 
Taldromyces radicus Palem et al., 2015 
Curvularia sp. Pandey et al., 2016 
Chaonephora infundibulifera Pandey et al., 2016 
Pestalotiopsis sp. Srivinasan & Muthusamy, 2009 
 
3.4 Conclusion 
In summary, we successfully identified the putative endophytic fungi isolated 
from different tissues of wildly grown Catharanthus roseus (purple and white) using a 
morphology and a molecular technique. The ITS 28s ribosomal RNA gene showed that 
the species were Colletotrichum gloeosporioides, Macrophomina phaseolina, 
Nigrospora sphaerica and Fusarium solani based on the sequences from a GenBank of 
BLAST system. Thus, these endophytic fungi will further be studied to find out the 
secondary metabolites containing natural products and bioactive compounds that could 
be produced by these endophytic fungi since they have been recognized as important 
and novel resources of natural bioactive products with a potential application in 
agriculture, medicine and food industry (Strobel et al., 2004; Gunatilaka, 2006; Verma 
et al., 2009) and a rich source of novel organic compounds with interesting biological 
activities and a high level of biodiversity (Giridharan et al., 2012). 
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CHAPTER 4: ANTIMICROBIAL AND HYDROLYTIC ENZYME 
PROPERTIES OF ENDOPHYTIC FUNGI  
FROM Catharanthus roseus 
4.1 Introduction 
The antibiotic resistance of pathogens has become a serious concern around the 
world (Aksoy & Unal, 2008) due to the evolution of resistance by existing pathogenic 
bacteria and fungi to commercial drugs, which is a relevant problem faced by health 
services (Costelloe et al., 2010). Resistance to drugs used in the treatment of many 
infectious diseases which caused by bacterial and fungal or parasitic is increasing, 
further complicating on rendering treatment of critical infectious illness (Ramos et al., 
2010). This phenomenon encourages the search for novel and effective antimicrobial 
metabolites (Liang et al., 2012). According to Levy (2005), increasing prevalence of 
multi-resistant bacteria has turned the search for new antimicrobial agents an important 
strategy for alternative therapies useful in the handling of difficult infections. 
Natural products remain to be an important source of new pharmaceutical 
products (Newman & Cragg, 2007). Since some of them are produced by the organisms 
as a result of selection in favor of improved defense against competing deleterious 
microorganisms (Ramos et al., 2010). The production of defensive secondary 
metabolites by them is important due to their original natural function in response to 
environmental challenges (Lu & Shen, 2004). 
Metabolites isolated from the fungal endophytes are good sources of novel 
secondary metabolic products having diverse structural groups and showing 
antibacterial, antifungal, anticancer, antiviral, antioxidant, insecticide, antidiabetic and 
immunosuppressive activities (Demain, 1999; Tan & Zou, 2001). Therefore, 
tremendous increase in interest on screening endophytes for their antimicrobial 
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activities (Liang et al., 2012). Furthermore, antimicrobial metabolites produced by 
endophytic fungi have many advantages, including sustainable use, no destruction of 
resources, easy large-scale industrial production and quality control (Liang et al., 2012). 
(Table 4.1). 
Other than that, endophytic fungi also yield enzyme; a biocatalyst protein in 
nature which catalyse the biochemical reaction taking place in the living cell without 
any overall change (Jain &  Jain, 2006) with a potential to hydrolyse several plant-
derived macromolecules (Zaferanloo et al., 2013). These enzymes are obtained from 
plants, animals and microorganisms (Boboye & Ajay, 2011). However, bacteria and 
fungi are mostly used microorganism for enzyme production (Maheswari & Sherley, 
2012) due to their fast growth rates and the ease of enzyme recovery (Boboye & Ajay, 
2011). They also involved in the metabolism of carbohydrate including the trials 
metabolism in microbes either in association with another organism such as plants or 
when they are unaccompanied (Boboye, 2004). Therefore, the objective of this research 
is to determine the antimicrobial properties of these endophytic fungi isolated from 
Catharanthus roseus plant and its hydrolytic enzymes produced that functionalize as 
degradation materials to penetrate plant tissues as endophytes. 
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Table 4.1: The secondary metabolites (antibiotic) produced by endophytic fungi 
from medicinal plants. 
Host 
plants 
Endophytic 
fungi 
Bioactive 
compounds 
References 
Gingko 
 biloba 
Chaetomium 
globosum 
Chaetoglobosins Zhang et al., 
2013 
Cinnamomum 
leanehirae 
Fusarium 
oxysporum 
Beauvericin Wang et al., 
2011 
Kennedia 
nigricans 
Streptomyces 
sp. 
Manumycin Castillo et al., 
2002 
Artemisia 
mongolica 
Colletotrichum 
gloeosporioides 
Colletotric acid Zou et al., 2000 
Artemisia 
annua 
Colletotrichum 
 sp.  
Artemisinin Lu et al., 2000 
Tripterygium 
wilfordii 
Cryptosporiopsis 
quercina 
Cryptoxin Strobel et al., 
1999 
Taxus 
brevifolia 
Pestalotiopsis 
microspora 
Pestalotiopsins Pulici et al., 
1996 
Tripterygium 
wilfordii 
Fusarium 
sp. 
Subglutinol A 
& B 
Lee et al., 1995 
4.2 Materials and methods 
4.2.1 Cultivation and extraction 
The preparation of crude fungal extract (CFE) was carried out following 
Wiyakrutta et al. (2004) with a minor modification where two types of extracts have 
been prepared; crude supernatant extract (CSE) and crude mycelia extract (CME) 
(Figure 4.1). Briefly, six pieces of the plug (1 cm) of each seven days grown fungal 
culture were inoculated into yeast extract sucrose broth (YESB) medium and incubated 
for 21 days at 25 °C under static condition. Then, the grown culture was harvested using 
filter separation methods. In order to prepare crude supernatant extract, the cell free 
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filtrate was extracted thrice with a dichloromethane (200 mL) and evaporated to dryness 
using a rotary evaporator. Meanwhile, for the preparation of crude mycelia extract, the 
mycelia biomass were freeze-dried and extracted twice with a mixture of 
dichloromethane: methanol (1:1, v/v) for 1 h. The extracted mycelia mixtures were then 
air dried and weighed before kept in the air tight container until further used. Both of 
the samples, crude mussel extract and crude supernatant extract were then dissolved 
separately in dimethylsulphoxide (DMSO) to obtain 1 g/mL of concentration. 
 
 
Figure 4.1: Schematic digram of he preparation of crude fungal extract (crude mycelia 
and crude supernatant extract). 
 
4.2.2 Preparation of microorganisms 
All pathogens for antimicrobial test were supplied by Department of 
Microbiology, Institute of Biological Sciences, Faculty of Malaya, Kuala Lumpur, 
Malaysia. 
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3.5 Fungal strain 
Aspergillus niger (plant pathogen) was cultured in a Petri dish contained Malt 
Extract Agar (MEA: OXOID) and incubated at 25 °C for 7 d. Meanwhile, Candida 
albicans (human pathogen) was cultured on Yeast Extract Peptone Dextrose agar 
(YEPD; 3 g of yeast extract, 10 g of peptone, 20 g of dextrose, 15 g of agar, and 1 L 
distilled water) and incubated at 25 °C for 7 d. After the incubation period, plates were 
stored in the 4 °C cool room until further use. 
4.2.2.1 Bacterial strain 
Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative) 
were cultured on Nutrient Agar (NA: OXOID) and incubated at 37 °C for 24 h. After 
incubation, these bacteria were stored in the 4 °C cool room until further use. 
4.2.3 Determination of antibacterial properties 
Four fungi strains had been identified earlier (C. gloeosporioides, M. 
phaseolina, N. sphaerica and F. solani) were tested for the antibacterial properties 
against S. aureus and E. coli. For this test, each fungal strain was prepared in three 
different samples; i) fungal plug, ii) crude mycelia extract and iii) crude supernatant 
extract. Then all these samples were cultured in different NA plate which has been lawn 
with S. aureus and E. coli separately. 
For the test using fungal plug samples, 1 cm diameter of the plug was taken 
from a seven days of culture. While above test for both samples of crude mycelia and 
crude supernatant extracts was conducted using the Kirby-Bauer disk diffusion 
technique (Bauer et al., 1966). It was prepared by using sterile disc that eventually had 
been added 20 µL of extract with different concentrations (1, 5 and 10 mg/mL). 
Erythromycin (15 µg) disc was used as a positive control while distilled water as a 
negative control (Figure 4.2). All plates were incubated at 37 °C for 24-48 h. After an 
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incubation period, plates were observed for zones of inhibition (ZoI) by using Equation 
4.1. 
ZoI  = (D - d)                                               ( Equation 4.1) 
Where, 
D= diameter of colony + clear zone  
d= diameter of colony 
                                           
 
Figure 4.2: The design of plates for antibacterial test against S. aureus and E. coli using 
fungal plug samples (A) and crude fungal extract (mycelia and supernatant) with 
different concentrations (B). All plates were incubated at 37 °C for 24-48 h. (F) Fungal 
plug; (F1, F2 and F3) disc with extract samples 1, 5 and 10mg/mL,   respectively; (+) 
erythromycin disc as a positive control and (-) distilled water  disc as a negative control. 
 
4.2.4 Determination of antifungal properties 
For antifungal properties, all fungi strains were tested against Aspergillus niger; 
a filamentous fungus (multicellular) and Candida albicans; a yeast (unicellular) using a 
confrontation culture method (Dennis and Webster, 1971). A one cm of the fungal plug 
of both sample and pathogenic fungal was placed on the same plate contained MEA and 
YEPD agar medium for A. niger and C. albicans respectively (Figure 4.3). The plates 
were incubated at 25 °C. After 7 days, the plates were observed for the antagonistic on 
A B 
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the inhibition of mycelia growth. The percentage of inhibition (POI) of mycelia growth 
was calculated according to Fokkema (1973): 
POI = (R1 – R2) x 100 ( Equation 4.2) 
R1
Where, 
R1 = radius of the pathogen away from the antagonist 
R2 = radius of the pathogen towards the antagonist 
Figure 4.3: The design of plates for antifungal test against A. niger and C. albicans 
using confrontation culture method. (A) pathogenic fungal plug samples and (B) 
antagonist; tested fungal plug sample (B). All plates were incubated at 25 °C for 7 d. R1 
and R2 are radius of pathogen. 
4.2.5 Hydrolytic enzymes test 
The endophytic fungi isolated from a Catharanthus roseus were qualitatively 
tested in the presence of its hydrolytic enzymes; cellulase, amylase and protease. The 
enzyme productivity of these fungi was expressed as the diameter of clear zone 
performed from the colony: 
EA = (D - d)  ( Equation 4.3) 
Where, 
D= diameter of colony + clear zone 
d= diameter of colony 
R1 
R2 
A 
B 
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4.2.5.1 Cellulase 
The qualitative test of cellulase for endophytic fungi isolated from a C. roseus 
was carried out according to Stewart et al. (1982). The media were prepared by using 
CMC medium (10 g of carboxymethyl cellulose, 6.5 g of sodium nitrate, 6.5 g of 
dipotassium phosphate, 0.3 g of yeast extract, 6.5 g of potassium chloride, 3 g of 
magnesium sulphate heptahydrate, 17.5 g of agar and 1 L of pure water; pH 6). The 
fungal plug with one cm sized was inoculated onto this medium for 5 d at 28 °C. To test 
the presence of enzyme, the plate was stained by using 1 % (w/v) of Congo red for one 
hour. Then, 1 M sodium chloride was introduced on the plate for 20 min for washing 
the previous staining. The enzyme prodictivity was determined when the yellow colour 
appeared around the fungal colonies on the plates and indicate the cellulase activity. 
4.2.5.2 Amylase 
The qualitative test of amylase for endophytic fungi isolated from a C. roseus 
was carried out according to Namasivayam (2009). Briefly, 1 cm of the fungal plug was 
inoculated onto starch agar medium (3 g of beef extract, 10 g of soluble starch, 12 g of 
agar and 1 L of purified water; pH 6). After 4 d incubated at 32 °C, the plate was tested 
for the presence of amylase by flooding 1 % (w/v) of iodine solution onto the fungal 
growth. The positive result was indicated by the formation of a clear zone on the plates.  
4.2.5.3 Protease 
The qualitative test of protease for endophytic fungi isolated from a C. roseus 
was carried out according to Hasan et al. (2013). A plug of fungus (1 cm) was placed 
onto a plated contained 5 g of peptone, 3 g of beef extract, 5 g sodium chloride, 15 g of 
agar and 1 L of distilled water with a pH 6. The plate was then incubated at 28 °C for 7 
d before checking with a mercuric chloride reagent and the clear zone appeared showed 
a positive result for this enzyme productivity. 
49 
4.2.6 Statistical analysis 
All data were analysed using IBM SPSS Statistics, Version 20 (IBM Corp., 
Armonk, New York). 
4.3 Results and discussion 
4.3.1 Antimicrobial properties 
Four endophytic fungi associated with a C. roseus plant were tested for 
antimicrobial properties; antibacterial and antifungal activities. Figure 4.5 showed the 
overall results of the antibacterial properties of three different sample preparations of 
these endophytic fungi. Eventhough previous research showed a positive result for these 
fungal strains (Table 4.2), but through this test, it can be seen that only a plug of N. 
sphaerica and CSE of F. solani were positive against S. aureus with the MIC of 1 
mg/mL with the inhibition zone of 0.1±0.05 cm (Figure 4.4). However, none of these 
endophytic fungi were significantly positive against E. coli (Table 4.3). 
Figure 4.4 The minimum inhibitory concentration (MIC) of a crude supernatant extract 
F. solani isolated from a C. roseus against S. aureus. 
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Figure 4.5: The antibacterial properties of endophytic fungi isolated from a C. roseus. 
All fungi were tested against pathogenic bacteria E. coli (row 1) and S. aureus (row 2) 
with a different samples; fungal plug (row A), crude supernatant extract (row B) and 
crude mycelia extract (row C). All plates were incubated for 48 h at 37 °C. The green 
boxes were the only plates that positive for antibacterial test against S. aureus which 
were N. sphaerica and F. solani. Positive control was erythromycin (+) and control  
distilled water (-). From the left; CG: C. gloeosporioides, MP: M. phaseolina,  
NS: N. sphaerica and FS: F. solani. 
 
 
 
 
 
 
 
A2 
A1 
B1 
B2 
C1 
C2 
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Table 4.2: Previous studies on antibacterial properties of endophytic fungi from plants 
that positively against pathogens. 
Endophytic fungi Host plant Pathogens References 
C. gloeosporioides Madhuca 
 longifolia 
S. aureus 
E. coli 
C. albicans 
Denise et al., 2008 
Cinnamomum 
malabatrum 
S. aureus 
E. coli 
C. albicans 
Packiaraj et al., 
2016 
Lannea 
corammendalica 
S. aureus 
E. coli 
Premjanu & 
Jaynthy, 2015 
Indigofera 
suffruticosa 
S. aureus 
E. coli 
Santos et al., 2015 
N. sphaerica Indigofera 
suffruticosa 
S. aureus 
E. coli 
Santos et al., 2015 
Swietenia 
macrophylla 
S. aureus Ibrahim et al., 2015 
Bauhinia 
racemosa 
E. coli Kandasamy, 2015 
F. solani Taxus 
baccata 
S. aureus 
E. coli 
C. albicans 
Tayung et al., 2011 
Solanum 
lycopersicum 
S. aureus 
E. coli 
Hateet et al., 2014 
Calotropis 
procera 
S. aureus 
E. coli 
Rani et al., 2017 
Withania 
somnifera 
S. aureus 
E. coli 
Salini et al., 2014 
It was reported that Gram-negative bacteria were more resistant compared to the 
Gram-positive bacteria (Cosa et al., 2006) which was commonly more sensitive to the 
tested extracts (Shan et al., 2007). This happened because both of bacteria have 
different samples of biochemical composition and structures of cell wall (Goyal et al., 
2008). Gram-negative bacteria possess an outer membrane and a unique periplasmic 
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space which is not found in Gram-positive bacteria (Duffy & Power, 2001).  This 
membrane contained lipopolysaccharide and protein layer that surrounding the 
peptidoglycan layer of the cell wall. Thus, it can prevent the bacteria from being 
attacked.  
Meanwhile, S. aureus was the most virulent species of Staphylococci which 
causes a variety of superficial and deep pyogenic infections such as skin infection, 
folliculitis, boils and food poisoning (Priya et al., 2012). Plus, it was a frequent and 
important human pathogen which is also found as non-pathogenic microorganisms in 
human samples (Creech et al., 2005) where almost a third of human were colonized 
with S. aureus (Grundmann et al., 2006). This species was the most virulent species and 
resistant to various antibiotics (Forbes et al., 1998). However, through this research, two 
fungal strains (N. sphaerica and F. solani) have the ability to resist the growth of S. 
aureus by inhibiting the protein, which cross-links peptidoglycans in the cell wall.  
5
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Table 4.3: The antibacterial properties of endophytic fungi isolated from a C. roseus against pathogenic bacteria 
E. coli and S. aureus with a different samples; fungal plug, crude supernatant extract and crude mycelia extract.  
plates were incubated for 48 h at 37 °C. Positive control was erythromycin (+) and negative control  
was distilled water (-). 
Samples Fungi 
Pathogenic bacteria 
S. aureus E. coli 
Diameter of inhibition zone (cm) 
F (+) (-) F (+) (-) 
Fungal plug 
CG - 2.20±0.06 - - - - 
MP - 2.20±0.05 - - - - 
NS 1.68±0.08 2.30±0.05 - - - - 
FS - 2.27±0.05 - - - - 
1 mg/mL 5 mg/mL 10 mg/mL (+) (-) 1 mg/mL 5 mg/mL 10 mg/mL (+) (-) 
Crude 
supernatant 
extract 
CG - - - 2.42±0.04 - - - - - - 
MP - - - 2.45±0.05 - - - - - - 
NS - - - 2.45±0.05 - - - - - - 
FS 0.1±0.05a 0.65±0.08b 1.28±0.22c 2.43±0.05 - - - - - - 
Crude 
mycelia 
extract 
CG - - - 2.46±0.05 - - - - - - 
MP - - - 2.45±0.05 - - - - - - 
NS - - - 2.48±0.04 - - - - - - 
FS - - - 2.42±0.04 - - - - - - 
Values presented are the means ± SD, (n = 3). Values within the same row and having different superscript letters are significantly different (p < 0.05). 
CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica and FS: F. solani. 
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The results on the antifungal properties determined by using an antagonistic 
method were shown in Figure 4.6. Among these endophytic fungi, F. solani and C. 
gloeosporioides gave the highest result on the antagonistic against A. niger and C. 
albicans, which were 80 % and 65 %, respectively (Table 4.4). 
 
Figure 4.6: The antifungal properties of endophytic fungi isolated from a C. roseus. 
These endophytic fungi were positively tested against pathogenic fungi C. albicans 
(row A) and A. niger (row B). All plates were incubated for 7 d at 25 °C. From the left; 
CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica and FS: F. solani. 
 
Table 4.4: The percentage of inhibition on endophytic fungi 
isolated from a C. roseus against pathogenic fungi A. niger           
and C. albicans. 
Fungi Percentage of inhibition (%) 
 A. niger C. albicans 
CG 75.71±0.06a  65.00±0.00a 
MP 48.50±0.00b 23.08±0.06b 
NS 57.06±0.10c 41.18±0.06c 
FS 79.75±0.06d 62.96±0.06d 
Values presented are the means ± SD, (n=3). Values within the same column and 
having different superscript letters are significantly different (p < 0.05). ND: Not 
detected, CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica and FS: 
F. solani. 
 
The antimicrobial properties of four fungal strains were ranged between 49 % to 
80 % and 23 % to 65 % of inhibition against A. niger and C. albicans respectively 
(Figure 4.7). Previous research reported by Cui et al. (2011) was also found that F. 
A 
B 
CG 
CG 
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solani isolated from the medicinal plant Aquilaria sinensis gave a positive effect on the 
pathogenic microbes; C. albicans, E. coli and S. aureus. A similar observation was 
reported against C. albicans and S. aureus which were isolated from a different 
medicinal plant; S. pallescens and C. leanehirae respectively (Sean & Jon, 2000; Wang 
et al., 2011). The highest antimicrobial properties from Fusarium sp. might be due to 
production of mycotoxins; the toxic secondary metabolites formed under appropriate 
environmental conditions by filamentous fungi (Bennett & Klich, 2003). 
Figure 4.7: The percentage of inhibition on the endophytic fungi isolated from a C. 
roseus against pathogenic fungi A. niger and C. albicans. CG: C. gloeosporioides, MP: 
M. phaseolina, NS: N. sphaerica and FS: F. solani. 
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4.3.2 Hydrolytic enzyme  
Endophytic fungi are known to have a huge proficiency in producing hydrolytic 
enzymes that act as a mechanism to protect itself against pathogenic invasion and to 
gain nutrition from the host such as cellulases (Caldwell, 2000), amylase (Choi et al., 
2005) and proteases (Petrini et al., 1992). Cellulase and protease play and important 
role in degradation of plant tissue. This caused the enzyme producing microbes 
penetrate the root and leaves of plants. Four endophytic fungi isolated from a C. roseus 
plant showed a positive result (Figure 4.8)  on cellulase enzyme. N. sphaerica has the 
highest enzyme activity, according to the clear zone produced after 5 days of incubation 
time (Table 4.5). This hydrolytic (Bhavsar & Bhalerao, 2012) and synergistic enzyme 
that used to break up the cellulose or lignocellulose into glucose or other 
oligosaccharide compounds (Chellapandi & Jani, 2008) for a wide range of applications 
(Bhavsar & Bhalerao, 2012).  
However, only three of these endophytic fungi were positively present for 
amylase and protease endophytes except M. phaseolina. Meanwhile, F. solani was a 
great producer of both enzymes with a diameter of clear zone 5.78±0.05 cm and 
5.65±0.06 cm respectively (Table 4.4). Amylase is universal enzyme being widespread 
in animals, fungi, plants, unicellular eukaryotes and prokaryotes, which is the most 
important enzymes used in biotechnology (Burhan et al., 2003). It is estimated that 
approximately 30 % of world enzymes production are amylase (Sivaramakrishnan et al., 
2006) and followed by report from Maheswari and Sherley (2012) that this enzyme 
leading the world’s market with a 65 % of enzymes production due to the high demand 
in various sectors such as food, pharmaceutical, textiles and detergents (Zaferanloo et 
al., 2013). However, this enzyme is widely used in the industry for starch hydrolysis 
(Maheswari & Sherley, 2012). 
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According to Maheswari and Sherley (2012) on their report, this enzyme is used 
commercially for the production of sugar syrups which is hydrolyzed from the starch 
which consists of glucose, maltose and higher oligosaccharide. Besides, it also catalyses 
the endo-cleavage of the α-1,4 glycoside linkages and release of short oligosaccharide 
with a  limitation of dextrin where the most important amylase for industrial and 
biotechnology applications are glucoamylases and α-amylases (Sivaramakrishnan et al., 
2006). In order to meet the demands of this enzyme, low cost medium is required for 
the production of amylase. Therefore, this demand has driven the exploitation of 
endophytes as enzyme sources for promising industrial applications in agriculture, 
medicine and food industry (Laird et al., 2006). Plant endophytic fungi spend the whole 
or part of their lifecycle colonizing the inside of healthy tissues of the host plants either 
inter/ and or intracellular (Zhao et al., 2010) where fungal sources of amylase are 
mostly terrestrial isolating such as Aspergillus sp. (Zaferanloo et al., 2013). 
Meanwhile, protease constitutes one of the most significant groups of industrial 
enzyme that are now used in a widespread range of industrial enzymes such as 
detergent, food, pharmaceutical, leather and silk industries (Adinarayana et al., 2003) 
due to the its physiological functions ranging from generalized protein digestion to the 
more specific regulated processes (Mussarat et al., 2000). This enzyme hydrolyzes 
peptide bonds of proteins and breaks them down into polypeptides or free amino acids. 
Thus, it differs in its substrate specificity, catalytic mechanism and active site 
(Sumantha et al., 2006). 
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Figure 4.8: The qualitative enzymes test of endophytic fungi isolated from a C. roseus. 
The green boxes were the only plates that positive for the qualitative enzymes test of 
cellulase (A), amylase (B) and protease (C). All strains were positive for the three 
enzymes except M. phaseolina which was only positive for cellulase and protease. From 
the left; CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica and FS: F. 
solani. 
 
Table 4.5: Enzyme productivity of the endophytic fungi isolated from a C. roseus plant. 
Fungi Diameter of clear zone (cm) 
 Cellulase Amylase Protease 
CG 0.10±0.00a 4.20±0.00a 0.45±0.06a 
MP 0.15±0.06a ND ND 
NS 2.80±0.00b 1.00±0.00b 2.30±0.00b 
FS 0.20±0.00c 5.78±0.05c 5.65±0.06c 
Values presented are the means ± SD, (n = 3). Values within the same column and having same superscript 
letters are not significantly different (p < 0.05). ND: Not detected, CG: C. gloeosporioides, MP: M. 
phaseolina, NS: N. sphaerica and FS: F. solani. 
 
 
A 
B 
C 
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4.4 Conclusions 
The antibacterial properties of the endophytic fungi C. gloeosporioides, M. 
phaseolina, N. sphaerica and F. solani were tested against S. aureus and E. coli. N. 
sphaerica showed a positive result against S. aureus (1.68 ± 0.08 cm) for plug sample. 
While crude supernatant extract (CSE) of F. solani showed a positive result against S. 
aureus (0.1 ± 0.05 cm, 0.65 ± 0.08 cm and 1.28 ± 0.22 cm) of concentrations (1 g/mL, 5 
g/mL and 10 g/mL) respectively. Meanwhile, the antifungal test showed that all these 
endophytic fungi were positive against A. niger and C. albicans. 
These endophytic fungi also showed a presence of cellulase enzyme through the 
qualitative enzymes test where N. sphaerica gave a highest diameter of clear zone 
2.80±0.00 cm. However, only C. gloeosporioides, N. sphaerica and F. solani  were 
positively present for amylase and protease where F. solani was a great producer of 
both enzymes with an diameter of clear zone 5.78±0.05 cm and 5.65±0.06 cm 
respectively. The results indicate these fungi were endophytes due to the capability to 
penetrate the plant cell by producing those enzymes. 
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CHAPTER 5:  ANTIOXIDANTS AND PHYTOCHEMICAL 
ANALYSIS OF ENDOPHYTIC FUNGI FROM Catharanthus roseus 
5.1 Introduction  
Antioxidant is a stable molecule which donates an electron to a rampaging free 
radical and terminates the chain reaction before vital molecules are damaged where it 
delays or inhibits cellular damage (Halliwell, 1995). The contribution of this free 
radicals in the pathogenesis of a large number of diseases is well acknowledged where a 
potent scavenger of free radicals may serve as a possible preventive intervention for the 
diseases (Gyamfi et al., 1999). A great variety of plants have been studied for a new 
source of natural antioxidants, especially phenolic and flavanoid compounds. These 
compouds derived from plants were proved to be potent antioxidant and free radical 
scavengers (Silva et al., 2005). Furthermore, plants also in particular have historically 
been viewed as the main source of novel bioactive compounds. However, plant 
availability is a limiting factor in the commercial success of some natural products due 
to a large quantity of plant is required to produce sufficient amounts of the bioactive 
compounds for clinical use. Thus, it has raised concerns like environmental degradation, 
loss of biodiversity and threat to endangered species (Alvin et al., 2014). 
Endophytes are the symbiotic microbes that inhabitat into the internal plant 
tissues without causing any apparent harm to their host and these endosymbiotic fungi 
found to synthesis bioactive secondary metabolites (Schulz et al., 2002; Strobel, 2003) 
like flavonoids, phenols, saponins, steroids, tannins and terpenoids. All these 
metabolites were used to protect the host from infectious diseases, parasitic infections 
and herbivore tissue invading pathogens (Abirami & Boominathan, 2016). However, 
they were poorly investigated group among other microorganisms since they were 
hidden within healthy host plant. (Srinivasan et al., 2010). In fact, they represent an 
61 
abundant and dependable source of novel bioactive compounds with huge potential for 
exploitations in a wide variety of medicinal, agricultural and industrial areas (Tan & 
Zou, 2001). The research on naturally occurring antioxidants had increased greatly and 
endophytic fungi are one of the potential source producing effective secondary 
metabolites in recent decades. Thus, the objective of this study is to determine the 
antioxidant properties of endophytic fungi from C. roseus plant and phytochemical 
analysis of these endophytic fungi. 
5.2 Materials and methods 
5.2.1 Determination of polyphenolics content in the endophytic fungi 
5.2.1.1 Total phenolic contents 
Total phenol content (TPC) was measured by the Folin-Ciocalteu method 
(Muller et al., 2010). Briefly, 20 µL of crude fungal extract (CFE) was mixed with 100 
µL of Folin-Ciocalteu reagent (diluted 10-fold with distilled water) in a 96-well 
microplate and incubated for 5 min before added with 75 µL of sodium carbonate 
solution (75 g/L). After 2 h incubated in darkness at room temperature, the absorbance 
was measured at 740 nm with a microplate reader (Tecan Sunrise, Austria). Gallic acid 
(100 – 1000 µM) was used as a standard for calibration and construction of a linear 
regression line and water was used as a blank. The total phenolic content was estimated 
as mg gallic acid equivalent (mg GAE)/g of dry extract. 
5.2.1.2 Total flavonoid contents 
Total flavonoid content (TFC) was measured according to Sasipriya and 
Siddhuraju (2012) and Abdulwali et al. (2014). Briefly, 50 µL of crude fungal extract 
(CFE) were added with 70 µL of distilled water and 15 µL of sodium nitrite solution (5 
%) in a 96-well microplate. The solutions were well mixed and incubated at room 
temperature for 5 min. Then, 15 µL of aluminium chloride solution (10 %) was added 
62 
 
into the mixture and incubated for 6 min. Then, 100 µL of 1 M sodium hydroxide 
solution was added and the absorbance was measured at 510 nm with a microplate 
reader (Tecan Sunrise, Austria). The total flavonoid content (TFC) was estimated from 
quercetin (200 – 1000 µM) standard curve and the results were expressed as mg 
quercetin equivalent (mg QE)/g of dry extract. 
5.2.2 Antioxidant activity assays 
5.2.2.1 DPPH radical – scavenging activity 
The free radical scavenging activity of crude fungal extract (CFE) was measured 
in terms of hydrogen donating ability by using DPPH radical according to Margithas et 
al. (2009) and Ablat et al. (2014). Briefly, 40 µL of crude fungal extracts with different 
concentrations (0.05 – 2 mg/mL) were mixed with 200 µL of 50 µM DPPH solution in 
methanol. Then, the mixture was immediately shaken before incubated in the dark at 
room temperature for 15 min. The absorbance was measured at 517 nm with a micro 
plate reader (Tecan Sunrise, Austria). Butylated hydroxyanisole (BHA) with 
concentrations of 5 – 80 µg/mL was used as a standard while the control was ethanol. 
The percentage of inhibition activity of the extracts was calculated according to the 
following equation:  
 
 
  DPPH radical scavenging activity (%)  = (A1 – A2) x 100 
                                                          A1                                             
 
(Equation 5.1) 
Where , 
A1 = Absorbance of control 
A2 = Absorbance of sample 
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The DPPH radical scavenging activity was estimated from the graph plotted 
against the percentage inhibition and compared with the standard in order to find the 
Half Maximal Inhibitory Concentration (IC50). 
5.2.2.2 Ferric reducing antioxidant power 
The ferric reducing antioxidant power (FRAP) activities of crude fungal extracts 
were measured according to Muller et al. (2010). Briefly, 20 µL of crude fungal extract 
(CFE) in methanol were mixed with 200 µL of daily prepared ferric reducing 
antioxidant power (FRAP) reagent contained 5 mL of 10 mM tripyridyl triazine (TPTZ) 
in 40 mM hydrogen chloride (HCl), 5 mL of 20 mM iron (III) chloride (FeCl3), and 50 
mL of 0.3 M acetate buffer; pH 3.6 in 96-well microplate. The formation of the TPTZ-
Fe2+ complex in the presence of antioxidant compounds in the extract was measured at 
595 nm with a microplate reader (Tecan Sunrise, Austria) after incubating for 8 min. 
Ferrous sulphate (FeSO4) solution (0.2 – 1 mm) was used for a standard calibration 
curve while the methanol was used as blank. The ferric reducing antioxidant power 
(FRAP) value was evaluated according to the linear regression between standard 
solutions and absorbance at 595 nm and the results were estimated as mmol Fe2+/g of 
dry extract from triplicated tests. 
5.2.2.3 Metal chelating activity 
Metal chelating activity or ferrous ion chelating activity (FCA) of the CFE was 
determined by measuring the formation of the ferrozine (Fe2+) complex, according to 
the procedure described by Decker and Welch (1990). 10 µL of extracts with different 
concentrations (50 – 800 µg/mL) were mixed with 120 µL of distilled water and 10 µL 
of 2 mM iron (II) chloride (FeCl2) in a 96-well microplate. 20 µL of 5 mM ferrozine 
was added to the mixture in order to initiate the reaction. The reaction mixture was 
incubated for 20 min at room temperature and was measured at 562 nm along with 
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EDTA-Na2 (5 – 80 µg/mL) as a standard metal chelator. 20 µL of distilled water was 
used as a blank while 100 µL of methanol was used as a control. The percentage of 
inhibition of ferrozine (Fe2+) complex formation was calculated according to the 
following formula:  
  Ferrous ion chelating activity (%)  = (A1 – A2) x 100 
                                                          A1                                             
 
(Equation 5.2) 
Where, 
A1 = Absorbance of control 
A2 = Absorbance of sample 
The metal chelating activity was estimated from the graph plotted against the 
percentage inhibition and compared with the standard in order to find the Half Maximal 
Inhibitory Concentration (IC50). 
5.2.3 Statistical analysis 
All data were analysed by using analysis of variance (IBM SPSS Statistics, 
Version 20; IBM Corp., Armonk, New York) to determine the significant studies on 
antioxidant and polyphenolics compounds. The regression among variables was showed 
in surface plot graph.  
5.3 Results and discussion 
Total phenolic contents (TPC) of the crude fungal extract (CFE) were tested 
using Folin-Ciocalteu’s reagent and expressed as Gallic acid equivalent (y = 0.0042x + 
0.0196, r2 = 0.9996) as in Appendix D. While total flavonoid contents (TFC) were 
measured based on the equivalent of quercetin (y = 0.0676x + 0.0142, r2 = 0.9997) as in 
Appendix E. The results showed that crude supernatant extract (CSE) of N. spherica 
had a higher value of both total phenolic contents (TPC) and total flavonoid contents 
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(TFC), which were 0.030 mg GAE/g and 0.038 ± 0.001 QE/g respectively (Table 5.1). 
The lowest total phenolic contents (TPC) and total flavonoid contents (TFC) were crude 
mycelia extract (CME) of N. sphaerica (0.023 mg GAE/g) and CFE of C. 
gloeosporioides (0.022 ± 0.001 QE/g) respectively. 
Table 5.1: The polyphenolics content of crude fungal extracts 
Samples TPC (mg GAE/g) TFC (mg QE/g) 
CG (CME) 0.024±0.001f 0.022±0.002f 
CG (CSE) 0.028±0.002c 0.022±0.001f 
MP (CME) 0.024±0.001f 0.034±0.001b 
MP (CSE) 0.027±0.001d 0.023±0.001e 
NS (CME) 0.023±0.000g 0.025±0.002d 
NS (CSE) 0.030±0.000a 0.038±0.001a 
FS (CME) 0.025±0.001e 0.029±0.003c 
FS (CSE) 0.029±0.001b 0.023±0.001e 
Values presented are the means ± SD, (n = 3). Values within the same column and having different 
superscript letters are significantly different (p < 0.05). CG: C. gloeosporioides, MP: M. phaseolina,  
NS: N. sphaerica, FS: F. solani, TPC: total phenolic contents, TFC: total flavonoid contents 
 CME: crude mycelia extract and CSE: crude supernatant extract. 
 
According to Huang et al. (2010), main natural products of secondary 
metabolites in plant and fungi were phenolic compounds where phenol and flavonoid 
compounds have been reported to possess different bioactivities. The antioxidant 
activity of crude fungal extracts was determined by using a methanol solution of DPPH 
reagent, ferric reducing antioxidant power (FRAP) and metal chelating activity (FCA). The 
DPPH radical scavenging activity of crude fungal extracts was tested at different 
concentrations (50 - 250 µg/mL) against the BHA as a standard (Appendix F). The 
percentage of DPPH radical scavenging activity ranged from 9.03 % to 17.15 % and 
0.26 % to 9.03 % of mycelia and supernatant samples respectively (Table 5.2). 
However, there was no data for half maximal inhibitory concentration (IC50) due to low 
scavenging activity.  
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Table 5.2: The DPPH radical- scavenging activity of crude fungal extracts 
Concent
ration 
(µg/mL) 
DPPH radical – scavenging activity (%) 
C. gloeosporioides M. phaseolina N. sphaerica F. solani VB VC BHA 
CME CSE CME CSE CME CSE CME CSE 
50 
20.73 
±0.15b 
8.94 
±0.77f 
26.49 
±0.15a 
3.97 
±0.26b 
9.52 
±0.69e 
0.26 
±0.02h 
10.75 
±0.90d 
4.46 
±0.38g 
17.57 
±0.83c 
10.17 
±0.86d 
0.32 
±0.01a 
100 
4.99 
±0.42d 
9.37 
±0.80b 
16.98 
±0.74a 
9.44 
±0.74b 
9.03 
±0.65b 
0.26 
±0.02e 
9.86 
±0.83b 
8.42 
±0.72c 
9.73 
±0.78b 
8.47 
±0.71c 
0.64 
±0.01b 
150 
9.19 
±0.75f 
7.76 
±0.67h 
20.82 
±0.20b 
10.12 
±0.79e 
16.80 
±0.64d 
9.03 
±0.40f 
10.14 
±0.85e 
8.29 
±0.71g 
24.89 
±0.39a 
18.76 
±0.81c 
0.96 
±0.26c 
200 
15.75 
±0.67e 
7.84 
±0.67h 
19.22 
±0.84c 
8.91 
±0.69g 
17.15 
±0.64d 
0.26 
±0.02i 
9.73 
±0.81f 
7.68 
±0.66h 
29.05 
±0.23a 
24.06 
±0.42b 
1.28 
±0.05d 
250 
8.83 
±0.72g 
13.39 
±0.59d 
25.53 
±0.08a 
11.21 
±0.45e 
10.29 
±0.76f 
0.26 
±0.02h 
15.85 
±0.71g 
8.16 
±0.70h 
24.98 
±0.36b 
24.22 
±0.44b 
1.60 
±0.34e 
Values presented are the means ± SD, (n = 3). Values within the same row and having different superscript letters are significantly different (p < 0.05). 
CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica, FS: F. solani, VB: Vinblastine, VC: Vincristine, CME: crude mycelia extract,  
CSE: crude supernatant extract and BHA:Butylatedhydroxyanisole.    
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The ferric reducing antioxidant power assay was measured based on the reaction 
between Fe3+-TPTZ and antioxidant potentials to form Fe2+-TPTZ in the fungus extract. 
The highest results showed that crude supernatant extract (CSE) of N. sphaerica 
produced 0.477±0.11 mmol Fe2+/g of extract while the lowest result was crude mycelia 
extract (CME) of C. gloeosporioides produced 0.336±0.01 mmol Fe2+/g of extract 
(Table 5.3). 
Table 5.3: Ferric reducing antioxidant power (FRAP) of crude fungal extracts 
Samples Ferric reducing antioxidant power 
(mmol Fe2+/g extract) 
CG (CME) 0.336±0.01f 
CG (CSE) 0.400±0.04d 
MP (CME) 0.357±0.01e
MP (CSE) 0.423±0.04c
NS (CME) 0.347±0.01d 
NS (CSE) 0.477±0.11b 
FS (CME) 0.340±0.01f 
FS (CSE) 0.437±0.11c
VB 0.103±0.01g 
VC 0.097±0.01g 
FeSO4 0.595±0.02
a
Values presented are the means ± SD, (n = 3). Values within the same raw and having different 
superscript letters are significantly different (p < 0.05). CG: C. gloeosporioides, MP: M. phaseolina, 
NS: N. sphaerica, FS: F. solani, VB: Vinblastine, VC: Vincristine, CME: crude mycelia extract, CSE: 
crude supernatant extract and  FeSO4: Ferrous sulphate. 
The metal chelating (FCA) activity was measured based on the chelation of 
ferrous ion with ferrozine and formed ferrous-ferrozine complex. The fungus extract 
was prepared in different concentrations (50-800 µg/mL) with data ranged from 12.33 
% to 39.72 % and 15.78 % to 39.16 % for crude mycelia extract (CME) and crude 
supernatant extract (CSE) respectively (Table 5.4 and Figure 5.1). 
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Table 5.4: Metal chelating activity (FCA) of crude fungal extracts. 
Samples Metal chelating activity (%) 
 Concentration (µg/mL) 
  50 100 200 400 800 
CS (CME) 20.48±0.87i 17.92±0.63h 27.55±0.78g 18.01±0.64h 16.53±0.50i 
CS (CSE)  38.86±0.05e 37.85±0.14d 39.16±0.01c 37.07±0.06d 37.78±0.13d 
MP (CME) 20.76±0.50i 18.65±0.73g 12.33±0.13j 18.47±0.72h 21.51±0.55h 
MP (CSE) 24.44±0.59h 18.96±0.70g 18.33±0.64h 18.67±0.67h 23.61±0.58g 
NS (CME) 37.25±0.10f 30.80±0.44e 32.16±0.21e 28.87±0.63f 27.08±0.75e 
NS (CSE) 34.42±0.22g 23.34±0.66f 30.64±0.36f 29.58±0.29e 26.66±0.78f 
FS (CME) 39.72±0.15d 30.59±0.75e 38.31±0.12d 29.06±0.88e 32.44±0.50e 
FS (CSE) 24.41±0.66h 19.06±0.79f 15.78±0.28i 25.79±0.49g 26.26±0.47f 
VB 95.97±0.03c 94.38±0.03b 93.18±0.05a 91.02±0.04b 89.55±0.02b 
VC 97.50±0.03b 95.27±0.00a 93.91±0.01a 92.52±0.05a 92.41±0.05a 
EDTA-Na2 98.29±0.11
a 93.71±0.05c 88.11±0.15b 83.31±0.09c 77.59±0.02c 
Values presented are the means ± SD, (n = 3). Values within the same row and having different superscript 
letters are significantly different (p < 0.05). CG: C. gloeosporioides, MP: M. phaseolina, NS: N. sphaerica, 
FS: F. solani, VB: Vinblastine, VC: Vincristine, CME: crude mycelia extract and                                      
CSE: crude supernatant extract. 
 
Figure 5.1: The antioxidant assay of crude fungal extracts from C. roseus plant by using 
ferrous ion chelating activity (FCA) at 562 nm. CG: C. gloeosporioides,  MP: M. 
phaseolina, NS: N. sphaerica, FS: F. solani, VB: Vinblastine, VC: Vincristine, CME: 
crude mycelia extract and CSE: crude supernatant extract. 
 
Through ferric reducing antioxidant assay, it showed that crude supernatant 
extract (CSE) of N. sphaerica has the highest result 0.477±0.11 mmol Fe2+/g of extract 
while crude mycelia extract (CME) of C. gloeosporioides has the lowest result 
0.336±0.01 mmol Fe2+/g of extract (Table 5.5). This analysis also revealed that crude 
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supernatant extract (CSE) of N. sphaerica has the highest properties for both 
antioxidant and polyphenolic; total phenolic content (TPC) and total flavonoid content 
(TFC). The previous studies also showed that N. sphaerica isolated from Bauhinia 
racemosa and Cresentia cujete has highest value for both antioxidant and phenolic 
content (Kandasamy et al., 2015; Prabukumar et al., 2015). 
According to Ablat et al. (2014), the extract containing the high value of total 
phenolic content and total flavonoid content showed the highest reducing power 
activity. The ferric reducing ability correlated well with total phenolic content (r2 = 
0.9996), total flavonoid content (r2 = 0.997) contents in the fraction and this was 
supported by Velioglr et al. (1998) from their report that the antioxidant activity of plant 
material is very well correlated with the content of phenolic compounds. The most 
significant studies on antioxidant and polyphenolics compounds were determined using 
an analysis of variance (ANOVA). Table 5.6 showed the regression of fungi*crude 
fungal extract*test was significantly different. It was supported by the surface plot 
where it showed  relationships among these variables (Figure 5.2). Besides, the 
correlation among test was also significant at the 0.01 level. 
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Table 5.5: Antioxidant and phytochemical analysis of crude fungal extracts. 
Samples DPPH 
 (IC50 
µg/mL) 
FRAP 
 (mmol Fe2+/g 
extract) 
FCA 
 (IC50 
µg/mL) 
TPC 
(mg GAE/g) 
TFC 
(mg QE/g) 
CG (CME) ND 0.336±0.01g ND 0.024±0.001f 0.022±0.002f 
CG (CSE) ND 0.400±0.04d ND 0.028±0.002c 0.022±0.001f 
MP (CME) ND 0.357±0.01e ND 0.024±0.001f 0.034±0.001b 
MP (CSE) ND 0.423±0.04c ND 0.027±0.001d 0.023±0.001e
NS (CME) ND 0.347±0.01f ND 0.023±0.000g 0.025±0.002d 
NS (CSE) ND 0.477±0.11a ND 0.030±0.000a 0.038±0.001a
FS (CME) ND 0.340±0.01f ND 0.025±0.001e 0.029±0.003c
FS (CSE) ND 0.437±0.11b ND 0.029±0.001b 0.023±0.001e 
VB ND 0.103±0.01h 22.00a - - 
VC ND 0.097±0.01i 22.00a - - 
Data are mean ± SD (n = 3). Values within the same row and having different superscript letters are significantly different (p 
> 0.05).  DPPH: diphenyl-1-picrylhydrazyl, FRAP: ferric reducing antioxidant power, FCA: ferrous ion chelating activity, 
TPC: total phenolic content, TFC: total flavonoid content, ND: not detected, CG: C. gloeosporioides, MP: M. phaseolina, 
NS: N. sphaerica, FS: F. solani, VB: Vinblastine, VC: Vincristine, CME: crude mycelia extract and CSE: crude 
supernatant extract. 
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Figure 5.2: The surface plots of fungi properties vs. crude fungal extract and 
endophytic fungi; A: 3D surface plot, B: contour plot, CG: C. gloeosporioides, 
MP: M. phaseolina, NS: N. sphaerica, FS: F. solani, CME: crude mycelia           
extract, CSE: crude supernatant extract. 
A 
B 
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Table 5.6: The ANOVA of antioxidant and polyphenolic content on                   
endophytic fungi from C. roseus. 
 Regression 
 Sum of Squares Mean Square F Sig. 
Fungi 0.000 0.000 0.011 0.919 
Fungi*CFE 0.006 0.003 0.089 0.915 
Fungi*CFE*Test 0.532 0.177 18.637 0.000 
 Correlation 
 Sum of Squares Pearson 
Correlation 
Sig.  
(1-tailed) 
Sig. 
 (2-tailed) 
Fungi 0.102 0.022 0.459 0.919 
CFE 0.186 0.089 0.339 0.679 
Test -2.901 -0.853 0.000** 0.000** 
Fungi (CG, MP, NS, FS); CFE (CME, CSE); Test (Antioxidant, TPC, TFC). **correlation was significant 
at the 0.01 levels. 
5.4 Conclusion 
N. sphaerica isolated from a medicinal plant C. roseus has potential as an 
antioxidant agent due to the significant result on both antioxidant and polyphenolic 
properties compared to the other species. Since there was no result on IC50 of DPPH 
radical – scavenging activity and IC50 of ferrous ion chelating activity, the data on ferric 
reducing antioxidant power was used as a comparison to a polyphenolic property. From 
the analysis, all CSE showed the highest result on the antioxidant properties through 
ferric reducing antioxidant power (FRAP) assay compared to crude mycelia extract 
(CME) of each endophytic fungi and this also applied to the total phenolic content 
(TPC) analysis. Thus, as a summary, the crude supernatant extract (CSE) samples were 
more productive on antioxidant and polyphenolic assays. Meanwhile, N. sphaerica has 
a great potential as the antioxidant agents and also could produce the polyphenolic 
compounds. 
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CHAPTER 6: ANTI-CARCINOGENIC ALKALOIDS 
VINBLASTINE AND VINCRISTINE PRODUCED BY 
ENDOPHYTIC FUNGI FROM Catharanthus roseus 
6.1 Introduction  
Endophytes are microbes that refer to microorganisms that live inside the tissues 
of plants without causing any apparent harm or diseases to the host plant (Strobel, 
2002). In fact, they promote the host plant’s growth and the formation of secondary 
metabolites related to the plant defence (Chandra et al., 2010; Petrini, 1991). They 
could produce valuable bioactive compounds with a varied application in both research 
and applied fields (Ravindra et al., 2014). Endophytic fungi spend the whole part of 
their life cycle living symbiotically within the healthy tissues of the host plant (Tan & 
Zou, 2001; Ravindra et al., 2014). It also has been recognized  as one of important and 
novel resources of natural bioactive products (Strobel et al., 2004) since most 
endophytes are capable of synthesizing bioactive compounds that may provide plants 
with a defence against pathogens (Guo et al., 2008). Some of these compounds have 
proven useful for discovering a novel drug (Yan et al., 2011).  
There are many reports that endophytic fungi isolated from a medicinal plant 
produce a new drug or compound that similar to the host plants (Table 6.1). All these 
findings will help to fill the demands of the drugs. In fact, the manufacturing cost of the 
drugs from endophytic fungi is cheaper than the production of the plants since it takes a 
shorter period to produce it. 
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Table 6.1: List of previous research on endophytic fungi that produces drugs. 
Host Plants Endophytic fungi Drugs References 
Phyllanthus amarus Trichothecium sp. Trichothecinol-A Ravindra et al., 2014 
Eugenia jambolana Cephalotheca faveolata Sclerotiorin Giridharan et al., 2012 
Camptotheca 
acuminate 
Fusarium solani Camptothecin Kusari et al., 2009 
Taxus brevifolia Taxomyces andreanale Taxol Strobel, 2002 
Tylophora indica Fusarium ssolani Taxol Merlin et al., 2012 
 
Catharanthus roseus or well known as a Madagascar periwinkle is a medicinal 
plant belonging to the family Apocynaceae (Gajalakshmi et al., 2013). Even though this 
plant is native to Madagascar; it also can be found in Malaysia and has been called as 
Kemunting Cina (Ayob & Simarani, 2016).  This plant is also well-known to produce a 
lot of important compounds, especially Vinca alkaloids vinblastine and vincristine 
(Krishnan, 1995; Manganey et al., 1979). Besides, this plant produces vindoline and 
catharanthine as well, which are the major monomer alkaloids as well as a biosynthetic 
precursor for vinblastine and vincristine (Noble, 1990).  
In 1960, vinblastine was introduced to treat certain types of cancer, including 
breast cancer, testicular cancer and Hodgkin’s disease (Armstrong et al., 1964). While 
in 1963, vincristine was introduced through oxidization of vinblastine to treat leukaemia 
(Evans et al., 1963). So far, there are only three reports on these alkaloids produced by 
the endophytic fungi which were Alternaria sp., Fusarium oxysporum and unidentified 
fungi from Catharanthus roseus (Guo et al., 1998; Zhang et al., 2000; Yang et al., 
2004). Thus, the objective of this research is to find a new endophytic fungus that could 
produce Vinca alkaloids, vinblastine and vincristine from the host plant C. roseus. The 
purified alkaloids will be tested for cytotoxicity test through MTT assay against breast 
cell line cancer. 
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6.2 Materials and methods 
6.2.1 Preparation of crude fungal extract and crude leaf extract 
The preparation of crude fungal extract (CFE) was carried out following 
Wiyakrutta et al. (2004) with a minor modification. Briefly, six pieces of the plug (1 
cm) of fungal growth culture were inoculated into a 250 mL conical flask containing 
250 mL of yeast extract sucrose broth (YESB) medium (20 g of yeast extract, 40 g of 
sucrose and 1L of distilled water with a pH 5.8). The flasks were then incubated at 25 
°C under static condition for 21 d. The grown culture was harvested by filter separation 
methods and used for crude extract preparation. 
The crude fungal extract from the cell free filtrate and mycelia biomass were 
prepared. The cell free filtrate was extracted thrice with a dichloromethane (200 mL) 
and evaporated to dryness using a rotary evaporator. The sample was weighed to 
constitute the crude fungal extract (CFE). Meanwhile, the mycelia biomass were freeze-
dried and extracted twice with a mixture of dichloromethane: methanol (1: 1, v/v) for 1 
h. The mycelia extract was air dried and weighed and kept in the air tight container until
further used. Both of crude extract were then dissolved separately in 
dimethylsulphoxide (DMSO) to obtain 1 g/mL of concentration. 
Meanwhile, the crude extracts of C. roseus leaves were prepared by soaking 5 g 
powdered of samples thrice with 90 % (v/v) ethanol (3 x 30 mL) for 12 h each at room 
temperature. The alcohol extract was filtered and concentrated in vacuo to 10 mL 
diluted with 10 mL of water, acidified with 10 mL of 3 % (v/v) hydrochloric acid and 
then washed with hexane (3 x 30 mL). The aqueous portion was basified with ammonia 
to pH 8.5 and extracted using chloroform (3 x 30 mL). The chloroform extract was 
washed with pure water, dried over sodium sulphate and concentrated under vacuum 
before dissolving in 10 mL of methanol (Gupta et al., 2005) (Appendix G). 
76 
 
6.2.2 Determination and purification of vinblastine and vincristine  
The presence of Vinca alkaloids in both crude extracts was detected using 
Liquid Chromatography–Mass Spectrometry (AB Sciex 3200Q Trap LCMS/MS), 
method Multiple Reaction Monitoring (MRM), equipped with a column Agilent Zorbax 
XDB C18 (150 mm x 4 mm x 5 µM) and buffered with (A) pure water, ammonium 
formate and formic acid, (B) acetonitrile, ammonium formate and formic acid. The 
experiment was run for 10 min and rapidly screened for the peaks because it should 
have two fragment ions from the same compounds for further confirmation of the peaks. 
The fungal crude extracts were then purified using High-Performance Liquid 
Chromatography (Agilent 1220 Infinity Gradient LC – G4294B) for vinblastine and 
vincristine. The 10 µL samples were injected in HPLC column C18 Merck (50 mm x 2 
mm x 1.5 µM) and isocratic elution was performed using methanol and Nano pure 
water with 0.01 % acetic acid at a flow rate of 1 mL/min. A dual wavelength 254 nm 
and 260 nm were used to detect the compounds eluting from the column. The purified 
vinblastine and vincristine were collected using an Agilent Fraction Collector (G1364C) 
and tested in a cytotoxicity test. 
6.2.3 Cytotoxicity activity (MTT assay) 
Cytotoxicity of vinblastine and vincristine produced by both crude extracts were 
assessed using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
(MTT; Sigma) assay against breast cell line cancer MDA-MB 231. The cancer cell was 
grown in Dulbecco’s Modified Eagle’s Medium (DMEM) and washed in phosphate 
buffer solution (PBS) before 100,000 cells were placed in each well of 96 well plates 
and treated with fungal extract. After 72 h incubated at 37 °C and 5 % CO2, the MTT 
reagent was removed from the plate and replaced with a DMSO and gently shaken for 
30 min. The absorption was determined at 570 nm. The percentage of inhibition (POI) 
was calculated using the formula: 
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  POI = (A1 – A2) x 100 
A1                                             
(Equation 6.1) 
Where, 
A1 = Absorbance of control 
A2 = Absorbance of sample 
The Half Maximal Inhibitory Concentration (IC50) was determined from the 
graph of samples concentration vs. percentage of inhibition. 
6.2.4 Determination of apoptosis by Annexin V/PI staining 
Experiment was carried out according to the manufacturer's instructions (FITC 
Annexin V Apoptosis Detection Kit I, BD Biosciences, USA). Cells were seeded in 6-
well plates at 1.3 x 105 cells/mL, incubated for 24 h and treated with fungal extract. 
Following 72 h incubation, the ﬂoating and adherent cells were collected and 
centrifuged at 100 x g to obtain a pellet. The pellet were washed twice with cold PBS 
and then resuspended in 1X binding buffer at a concentration of 1 x 106 cells/mL. Then, 
100 µL of the resuspended pellet (1 x 105 cells) was transferred to a 5 mL polystyrene 
round-bottom tube and stained with 5 µL of Annexin V-ﬂuorescein isothiocyanate 
(FITC) and 5 µL of propidium iodide (PI). The cells were then gently vortexed and 
incubated for 15 min at RT (25° C) in the dark. Thereafter, 400 µL of 1X binding buffer 
was added to each tube. Samples were analysed immediately by CyAN ADP ﬂow 
cytometer (Beckman Coulter, Brea, CA, USA). For each sample, 10,000 events were 
collected. The results were analysed by using Summit v4.3 software (Beckman Coulter, 
Brea, CA, USA). 
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6.2.5 Statistical analysis 
All data were analysed using IBM SPSS StatistiCG, Version 20 (IBM Corp., 
Armonk, New York). 
6.3 Results and discussion 
Five endophytic fungi were isolated from the leaf and roots of C. roseus plant 
and have been identified as a C. gloeosporioides, M. phaseolina, N. sphaerica and 
F.solani. The crude fungal extract was prepared by using the 21 days of fungal cultured 
(Figure 6.1) while the crude leaf extract was prepared using a dried leaf of wildly grown 
C. roseus - purple and white. The crude leaf extract of C. roseus showed a presence of 
both vinblastine and vincristine. However, only crude mycelia extract of N. sphaerica 
and C. gloeosporioides showed a positive result on vinblastine and vincristine 
respectively by using Liquid Chromatography–Mass Spectrometry (LCMS). It was 
determined by the presence of two fragment ions from a peak in the same compounds 
and indicated a confirmation of the compound detected even though the retention time 
slightly different among all samples (Figure 6.2 and Figure 6.3). Meanwhile, there was 
no result on both alkaloids in a crude supernatant fungal extract. This result indicated 
that the vinblastine and vincristine were intracellularly produced by both fungi. 
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Figure 6.1: The crude fungal extract was prepared by using a broth culture technique 
where the inoculum was cultured in a yeast extract sucrose broth (YESB) medium and 
incubated at 25 °C under static condition (A). After 21 days (B), the cultured can be 
harvested using filter separation methods and the crude mycelia extract (C) and crude 
supernatant extract (D) had been prepared. 
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Figure 6.2: The Liquid Chromatography–Mass Spectrometry (LCMS) chromatograph of commercial standard vinblastine (A), crude 
mycelia extract of N .sphaerica isolated from C. roseus plant (B), crude leaf extract of C. roseus - purple (C) and crude leaf extract 
of C. roseus – white (D) showed a presence of vinblastine at retention time of 4.91 min, 4.94 min, 5.13 min and 5.26 min respectively. 
Blue line = 1st fragment ion, Red line = 2nd fragment ion. 
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Figure 6.3: The Liquid Chromatography–Mass Spectrometry (LCMS) chromatograph of commercial standard vincristine (A), crude 
mycelia extract of C. gloeosporioides isolated from C. roseus plant (B), crude leaf extract of C. roseus - purple (C) and crude leaf 
extract of C. roseus – white (D) showed a presence of vincristine at retention time of 4.72 min, 4.74 min, 4.80 min and 4.86 min 
respectively. Blue line = 1st fragment ion, Red line = 2nd fragment ion. 
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Purified vinblastine was obtained by using High-Performance Liquid 
Chromatography (HPLC). The crude mycelia extract of this fungus and crude leaf 
extract were eluted for five minutes of retention time when loaded on the analytical C18 
column with a flow rate of 1 ml/min. The crude mycelia extract of N. sphaerica 
fermented in yeast extract sucrose broth and crude leaf extract of C. roseus produced 
0.868 µg/mL and 0.666 µg/mL of vinblastine respectively. From the chromatograph of 
HPLC, the retention time for almost each peak of crude extract, fungal showed a same 
result with a crude leaf extract since the fungal was isolated from the C. roseus (Figure 
6.4 and Figure 6.5). 
Cytotoxicity of alkaloids produced by endophytic fungus N. sphaerica and C. 
roseus were tested against human breast carcinoma MDA-MB 231 cell line cancer with 
various concentrations (6.35 to 400 µg/mL). The results showed it was significantly 
different from concentrations of alkaloids, but not from the sources of these alkaloids 
(Table 6.2). The test showed a positive result with a Half Maximal Inhibitory 
Concentration (IC50) value of > 32 µg/mL and 350 µg/mL for CFE and CLE 
respectively (Figure 6.6). This happened when the Vinca alkaloid was binding to beta-
tubulin and disruption of microtubule function during mitosis, which turn leads to 
mitosis arrest and cell death (Damen et al., 2010). Therefore, after treated 72 h with the 
alkaloids produced by CFE and CLE, some of the breast cancer cells started to die  
(Figure 6.7). The apotopsis assay was carried out to support the data on MTT assay by 
using AnnexinV staining assay where the important mechanism of this assay is 
programmed cell death or apoptosis in the chemotherapeutic technique (Dickson & 
Schwartz, 2009; Call et al., 2008). 
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Figure 6.4: The High-Performance Liquid Chromatography (HPLC) chromatograph of 
commercial standard vinblastine (A), vinblastine produced by the crude mycelia extract 
of N.sphaerica isolated from C. roseus – white plant (B) and crude leaf extract of C. 
roseus – white (C) has been purified at retention time of 1.52 to 1.57 min. 
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Figure 6.5: The High-Performance Liquid Chromatography (HPLC) chromatograph of 
commercial standard vincristine (A), vincristine produced by the crude mycelia extract 
of C. gloeosporioides isolated from C. roseus – purple plant (B) and crude leaf extract 
of C. roseus – purple (C) has been purified at retention time of 1.51 to 1.56 min. 
A 
B 
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This assay may distinguish between cell death or late apoptosis, early apoptosis 
and intact cells (Cheng et al., 2004) by staining with Annexin VFITC and propidium 
iodide (PI) (Lay et al., 2014). The result showed that breast cell line cancer MDA-MB 
231 treated with alkaloids purified from N. sphaerica, C. gloeosporioides, C. roseus 
(white and purple) have a percentage of early apoptosis 3.1 %, 1.61 %, 1.20 % and 1.34 
% , and a percentage of late apoptosis 4.57 %, 7.82 %, 4.15 % and 3.16 %  
respectively.These data were compared with the sample treated with commercial 
standard alkaloid vinblastine and vincristine as where they have a percentage of early 
apoptosis 6.83 % and 10.73 % and a percentage of late apoptosis 8.04 % and 9.75 % 
respectively. Meanwhile, the control sample showed a percentage of early and late 
apoptosis 16.18 % and 7.94 % respectively. All these data were shown in Figure 6.8 and 
6.9. The results indicated that the effects of programmed cell death or apoptosis on 
breast cell line cancer MDA-MB 231 were induced by purified alkaloids (vinblastine 
and vincristine) from both crude fungal extract and crude leaf extract.   
Jordan and Wilson (2004) in their reports also mentioned that the anticancer 
activity of these alkaloids was attributed to their ability to disturb microtubules 
metaphase arrest in dividing cell. Before this only one report on vinblastine produced 
from endophytic fungi Alternaria sp. isolated from the C. roseus (Gua et al., 1998). 
This new finding will help to fill the demand of this valuable natural product for cancer 
treatment. This was supported by Ravindra  et al. (2011) that  among the metabolites 
produced by the endophytic fungi attention is attracted to the compound with anti-
cancer properties. So far, there were 100 anticancer substances classified in 19 different 
chemical classes with an activity against 45 different cancer cell lines that have been 
isolated from 50 fungal species (Abdulmyanova et al., 2015). 
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Table 6.2: The percentage of inhibition on MTT assay of alkaloids purified from a 
crude mycelia extract (CME) of C. gloeosporioides, N.sphaerica isolated from C. 
roseus plant  and a crude leaf extract (CLE) of C. roseus against breast cell line cancer 
MDA-DB 231 with various concentrations 6.35 to 400 µg/mL. 
Percentage of inhibition (%) 
Concentration (µg/mL) 
 6.35 12.50 25.00 50.00 100.00 200.00 400.00 
CG 42.36±0.00a 45.14±0.00c 49.31±0.00e 29.17±0.00g 34.72±0.00i 30.56±0.00k 42.46±0.01m 
NS 31.17±0.01a 30.52±0.00c 41.56±0.00e 63.64±0.00g 61.04±0.00i 61.67±0.00k 60.39±0.00m 
CR(P) 11.11±0.00a 14.14±0.00c 25.02±0.00e 27.27±0.00g 20.20±0.01i 24.24±0.00k 35.35±0.00m 
CR(W) 27.89±0.00a 45.26±0.00c 30.53±0.00e 25.79±0.01g 29.47±0.01i 32.63±0.01k 55.26±0.00m 
VB 49.57±3.35b 49.52±3.91d 50.69±1.55f 52.83±5.94h 56.24±6.34j 64.54±5.28l 75.88±6.61n 
VC 44.22±6.35b 48.10±7.40d 52.06±5.10f 57.19±8.43h 64.58±11.71j 71.25±8.39l 79.50±7.45n 
Values presented are the means ± SD, (n = 3). Values within the same column and having same superscript 
letters are not significantly different (p < 0.05). CG: C. gloeosporioides, NS: N. sphaerica, CR(P): C. 
roseus purple, CR(W): C. roseus white, VB:Vinblastine and VC:Vincristine. 
  
  
 
Figure 6.6: The MTT assay of alkaloids purified from a crude mycelia extract (CME) 
of C. gloeosporioides (A), N. sphaerica (B) isolated from C. roseus plant  and a crude 
leaf extract (CLE) of C. roseus-purple (C) and C. roseus-white (D) against breast cell 
line cancer MDA-DB 231 with various concentrations 6.35 to 400 µg/mL. 
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Figure 6.7: The structure of breast cell line cancer MDA-DB 231 (1) before treated with alkaloids purified from a crude 
mycelia extract of N. sphaerica (A1), crude mycelia extract (CME) of C. gloeosporioides  (B1), crude leaf extract (CLE) of C. 
roseus - white (C1) and crude leaf extract of C. roseus – purple (D1). (2) After 72 h treated with different concentration of 
vinblastine and vincristine produced by all crude extracts, the structure of breast cell lines changed from a rod shape into a 
round shape (red circle). 
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Figure 6.8: The percentage of viable, early apoptotic cells, late apoptotic/early necrotic cells and 
late necrotic cells of breast cell line cancer MDA-DB 231 after 72 h treated with alkaloids purified 
from a crude mycelia extract C. gloeosporioides (A) and  N. sphaerica (B), crude leaf extract of C. 
roseus - purple (C) and C. roseus – white (D), commercial standard vinblastine (E) and vincristine 
(F) . The result was determined by flow cytometry analysis using Annexin-V/PI. R5= viable cells, 
R6= Early apoptosis, R4= Late apoptosis/ early necrosis and R3= Late necrosis. 
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Figure 6.9: The percentage of viable, early apoptotic cells, late apoptotic/ early necrotic 
cells and late  necrotic cells of untreated and alkaloids-treated MDA-MB-231 cells for 
72 h as determined by flow cytometry analysis using Annexin-V/PI. Values presented 
are the means ± SD, (n = 3). Values having the same superscript letters are not 
significantly different (p < 0.05). CG: C. gloeosporioides, NS: N. sphaerica, CRP: C. 
roseus purple, CRW: C. roseus white, VB:Vinblastine and VC:Vincristine. 
6.4 Conclusion 
This is the first report on N. sphaerica and C. gloeosporioides isolated from a 
medicinal plant C. roseus. The crude mycelia extract (CME) of N. sphaerica was 
positive produced vinblastine with a concentration of 0.868 µg/mL compared to the 
crude leaf extract (CLE) which produced a concentration of 0.666 µg/mL. While the 
crude mycelia extract of C. gloeosporioides was positive produced vincristine. However 
the concentration was very low. The cytotoxicity test using the 3-(4,5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay against breast cell line cancer 
MDA-MB 231  for both extracts  showed that vinblastine produced by crude mycelia 
extract of N. sphaerica has a better half maximal inhibitory concentration (IC50) > 32 
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µg/mL compared to the vinblastine from a crude leaf extract of C. roseus  > 350 µg/mL. 
The  programmed cell death or apoptosis assay gave a solid result of anticancer by 
inducing the purified alkaloids from both crude fungal extract and crude leaf extract to 
the breast cell line cancer MDA-MB 231. Currently, the commercial vinblastine in the 
market was produced by C. roseus. However, it takes almost one year before it is ready 
for harvesting. On the other hand, vinblastine produced by N. sphaerica only takes only 
a month (cultivation, extraction and purification) before it is ready to use. As a 
conclusion, the vincristine and vinblastine produced by crude mycelia extract of C. 
gloeosporioides and N. sphaerica respectively could be produced faster with a huge 
amount instead of current resource of this alkaloid; C. roseus.  
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CHAPTER 7: CONCLUSIONS AND RECOMMENDATIONS 
7.1 Conclusions 
The main objective of this research was to find a new endophytic fungus that 
could produce vinca alkaloids, vinblastine and vincristine from the host plant 
Catharanthus roseus. Thus, this chapter will conclude all the findings regarding to all 
the endophytic fungi associated with a C. roseus plant. 
1. In summary, we successfully identified the putative endophytic fungi isolated
from different tissues of wildly grown C.  roseus (purple and white) using a 
morphology and a molecular technique. The ITS 28s ribosomal RNA gene 
showed that the species were C. gloeosporioides, M. phaseolina, N. sphaerica 
and F.  solani based on the sequences from a GenBank of BLAST system. Thus, 
these endophytic fungi were further studied to determine the natural bioactive 
secondary metabolites. 
2. The antibacterial properties of the endophytic fungi C. gloeosporioides, M.
phaseolina, N. sphaerica and F. solani were tested against S. aureus and E. coli. 
N. sphaerica showed a positive result against S. aureus (1.68 ± 0.08 cm) for 
plug sample. While crude supernatant extract (CSE) of F. solani showed a 
positive result against S. aureus (0.1 ± 0.05 cm, 0.65 ± 0.08 cm and 1.28 ± 0.22 
cm) of concentrations (1 g/mL, 5 g/mL and 10 g/mL) respectively. Meanwhile, 
the antifungal test showed that all these endophytic fungi were positive against 
Aspergillus niger and Candida albicans. These endophytic fungi also showed a 
presence of cellulase enzyme through the qualitative enzymes test where N. 
sphaerica has a highest diameter of clear zone 2.80±0.00 cm. However, only 
three of these endophytic fungi were positively present for amylase and protease 
endophytes except M. phaseolina where F. solani was a great producer of both 
92 
 
enzymes with diameter of clear zone 5.78±0.05 cm and 5.65±0.06 cm 
respectively. 
3. N. sphaerica isolated from a medicinal plant C. roseus has a potential as an 
antioxidant agent (based on FRAP test result) due to the significant result on 
both antioxidant and polyphenolic properties. From the analysis, all crude 
supernatant extract (CSE) showed the highest result on the antioxidant 
properties through ferric reducing antioxidant power (FRAP) assay compared to 
crude mycelia extract (CME) of each endophytic fungi and this also applied to 
the total phenolic content analysis. Thus, as a summary, the crude supernatant 
extract (CSE) samples were more potent on antioxidant and polyphenolic 
assays. Meanwhile, N. sphaerica has a great potential as the antioxidant agents 
and also could produce the polyphenolic compounds. 
4. The crude mycelia extract (CME) of N. sphaerica was positive produced 
vinblastine with a concentration of 0.868 µg/mL compared to the crude leaf 
extract (CLE) which produced a concentration of 0.666 µg/mL. While the crude 
mycelia extract of C. gloeosporioides was positive for vincristine. However the 
concentration was very low. The cytotoxicity test using the 3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay against 
breast cell line cancer MDA-MB 231  for both extracts  showed that vinblastine 
produced by crude mycelia extract of N. sphaerica has a better half maximal 
inhibitory concentration (IC50) > 32 µg/mL compared to the vinblastine from a 
crude leaf extract of C. roseus  > 350 µg/mL. The apoptosis test by staining with 
Annexin VFITC and propidium iodide showed that breast cell line cancer MDA-
MB 231 treated with alkaloids purified from N. sphaerica, C. gloeosporioides, 
C. roseus (white and purple) have a percentage of early apoptosis 3.1 %, 1.61 %, 
1.20 % and 1.34 % , and a percentage of late apoptosis 4.57 %, 7.82 %, 4.15 % 
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and 3.16 %  respectively. Currently, the commercial vinblastine in the market 
was produced by C. roseus. However, it takes almost one year before it is ready 
for harvesting. On the other hand, vinblastine produced by N. sphaerica only 
takes only a month (cultivation, extraction and purification) before it is ready to 
use. As a conclusion, the vincristine and vinblastine produced by crude mycelia 
extract of C. gloeosporioides and N. sphaerica respectively could be produced 
faster with a huge amount instead of current resource of this alkaloid; C. roseus. 
7.2 Recommendations for future works 
Through this research, it was motivating to find out other secondary metabolites could 
be produced by endophytic fungi N. sphaerica since it showed a great data on all 
aspects that we studied. The optimization of the anti-carcinogenic alkaloids produced by 
these endophytic fungi could be studied in order to fulfil the demands of these drugs in 
pharmaceutical industries. 
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